{
  "hash": "8cdd827a46ef60ca81478a896fbbd865",
  "result": {
    "engine": "knitr",
    "markdown": "---\ntitle: \"Supplementary Information\"\nbibliography: references.bib\nexecute:\n  cache: false\n  message: false\n  warning: false\neditor: visual\n---\n\n::: {.cell}\n\n```{.r .cell-code .hidden}\nlibrary(data.table)\n```\n:::\n\n\n## Supplementary Results\n\n\n::: {.cell}\n\n```{.r .cell-code .hidden}\n#### Import and prepare results ####\nresults <- MSTExplorer::load_example_results()\nresults <- HPOExplorer::add_hpo_name(results)\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAdding HPO names.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nTranslating ontology terms to names.\n```\n\n\n:::\n\n```{.r .cell-code .hidden}\nresults <- MSTExplorer::map_celltype(results)\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nMapping cell types to cell ontology terms.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAdding stage information.\n```\n\n\n:::\n:::\n\n::: {.cell}\n\n```{.r .cell-code .hidden}\n## Must use `cache.lazy=FALSE` because sparse matrices not yet supported for caching\nctd_list <- MSTExplorer::load_example_ctd(c(\"ctd_DescartesHuman.rds\",\n                                           \"ctd_HumanCellLandscape.rds\"),\n                                         multi_dataset=TRUE)\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nLoading ctd_DescartesHuman.rds\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nLoading ctd_HumanCellLandscape.rds\n```\n\n\n:::\n:::\n\n::: {#cell-fig-evidence-histograms .cell}\n\n```{.r .cell-code .hidden}\n#| label: fig-evidence-histograms\n#| fig-cap: Distribution of evidence scores at each processing step.\n\nevidence_plot <- HPOExplorer::plot_evidence(save_path = here::here(\"inst/pages/chapter1/figures/fig-evidence-histograms.pdf\"),\n                                            width=5,\n                                            height=8)\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nGathering data from GenCC.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nImporting cached file.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nEvidence scores for: \n - 10390 diseases \n - 5142 genes\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: 2024-03-01\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nGathering data from GenCC.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nImporting cached file.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nEvidence scores for: \n - 10390 diseases \n - 5142 genes\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: 2024-03-01\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: phenotype_to_genes.txt\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAnnotating gene-disease associations with Evidence Score\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAnnotating phenos with Disease\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: phenotype.hpoa\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nGathering data from GenCC.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nImporting cached file.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nEvidence scores for: \n - 10390 diseases \n - 5142 genes\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: 2024-03-01\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nConstructing HPO gene x phenotype matrix.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAnnotating gene-disease associations with Evidence Score\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAnnotating phenos with Disease\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: phenotype.hpoa\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nGathering data from GenCC.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nImporting cached file.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nEvidence scores for: \n - 10390 diseases \n - 5142 genes\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: 2024-03-01\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n`stat_bin()` using `bins = 30`. Pick better value with `binwidth`.\n`stat_bin()` using `bins = 30`. Pick better value with `binwidth`.\n`stat_bin()` using `bins = 30`. Pick better value with `binwidth`.\n`stat_bin()` using `bins = 30`. Pick better value with `binwidth`.\n`stat_bin()` using `bins = 30`. Pick better value with `binwidth`.\nSaving plot --> /Users/bms20/Desktop/Rare Disease Celltyping/rare_disease_celltyping/inst/pages/chapter1/figures/fig-evidence-histograms.pdf\n\n`stat_bin()` using `bins = 30`. Pick better value with `binwidth`.\n`stat_bin()` using `bins = 30`. Pick better value with `binwidth`.\n`stat_bin()` using `bins = 30`. Pick better value with `binwidth`.\n`stat_bin()` using `bins = 30`. Pick better value with `binwidth`.\n`stat_bin()` using `bins = 30`. Pick better value with `binwidth`.\n```\n\n\n:::\n\n::: {.cell-output-display}\n![Distribution of evidence scores at each processing step.](supplement_files/figure-html/fig-evidence-histograms-1.png){#fig-evidence-histograms width=672}\n:::\n:::\n\n::: {.cell}\n\n```{.r .cell-code .hidden}\n#### Across CTD ####\nvalidate_associations_correlate_ctd_out <- MSTExplorer::validate_associations_correlate_ctd(\n  results=results,\n  # filters=list(stage=\"Fetus\"),\n  group_var=\"ctd\")\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nCell type columns already present. Skipping mapping.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAdding logFC column.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nCasting results.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n13 comparable celltypes.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n10945 comparable phenotypes.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n10 comparable celltypes @FDR<0.05.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n554 comparable phenotypes @FDR<0.05.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nGenerating plots.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nRegistered S3 method overwritten by 'ggside':\n  method from   \n  +.gg   ggplot2\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nGathering statistics.\n```\n\n\n:::\n\n```{.r .cell-code .hidden}\n## Replace p-values of exactly 0 with smallest number R can compute\nvalidate_associations_correlate_ctd_out$data_stats$p.all$summary_data$p.value <- max(validate_associations_correlate_ctd_out$data_stats$p.all$summary_data$p.value,\n                  .Machine$double.xmin)\n\n#### Within CTD: across developmental stages ####\nvalidate_associations_correlate_ctd_out_hcl <- MSTExplorer::validate_associations_correlate_ctd(\n  results=results,\n  filters= list(ctd=c(\"HumanCellLandscape\"), \n                stage=c(\"Fetus\",\"Adult\")),\n  group_var=\"stage\")\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nCell type columns already present. Skipping mapping.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nlogFC already exists in results. Use `force_new=TRUE` to overwrite.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nFiltered 'ctd' : 848,078 / 2,206,994 rows dropped.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nFiltered 'stage' : 54,795 / 1,358,916 rows dropped.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nCasting results.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n38 comparable celltypes.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n10959 comparable phenotypes.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n33 comparable celltypes @FDR<0.05.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n1584 comparable phenotypes @FDR<0.05.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nGenerating plots.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nGathering statistics.\n```\n\n\n:::\n:::\n\n::: {#fig-ctd-correlation .cell layout-ncol=\"2\"}\n\n```{.r .cell-code .hidden}\n#| label: fig-ctd-correlation\n#| layout-ncol: 2\n#| fig-cap: Inter- and intra-dataset validation across the different CellTypeDataset (CTD) and developmental stages. Correlations are computed using Pearson's correlation coefficient. Point density is plotted using a 2D kernel density estimate.\n#| fig-subcap:\n#| - Correlation between the uncorrected p-values from all phenotype-cell type association tests using the Descartes Human vs. Human Cell Landscape CTDs.\n#| - Correlation between the $log_{10}(fold-change)$ from significant phenotype-cell type association tests ($FDR_{p,c}<0.05$) using the Descartes Human vs. Human Cell Landscape CTDs.\n#| - Correlation between the uncorrected p-values from all phenotype-cell type association tests using the Human Cell Landscape fetal samples vs. Human Cell Landscape adult samples.\n#| - Correlation between the $log_{10}(fold-change)$ from significant phenotype-cell type association tests ($FDR_{p,c}<0.05$) using the Human Cell Landscape fetal samples vs. Human Cell Landscape adult samples.\n\nvalidate_associations_correlate_ctd_out$plot$p.all\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n`stat_xsidebin()` using `bins = 30`. Pick better value with `binwidth`.\n`stat_ysidebin()` using `bins = 30`. Pick better value with `binwidth`.\n```\n\n\n:::\n\n```{.r .cell-code .hidden}\n#| label: fig-ctd-correlation\n#| layout-ncol: 2\n#| fig-cap: Inter- and intra-dataset validation across the different CellTypeDataset (CTD) and developmental stages. Correlations are computed using Pearson's correlation coefficient. Point density is plotted using a 2D kernel density estimate.\n#| fig-subcap:\n#| - Correlation between the uncorrected p-values from all phenotype-cell type association tests using the Descartes Human vs. Human Cell Landscape CTDs.\n#| - Correlation between the $log_{10}(fold-change)$ from significant phenotype-cell type association tests ($FDR_{p,c}<0.05$) using the Descartes Human vs. Human Cell Landscape CTDs.\n#| - Correlation between the uncorrected p-values from all phenotype-cell type association tests using the Human Cell Landscape fetal samples vs. Human Cell Landscape adult samples.\n#| - Correlation between the $log_{10}(fold-change)$ from significant phenotype-cell type association tests ($FDR_{p,c}<0.05$) using the Human Cell Landscape fetal samples vs. Human Cell Landscape adult samples.\n\nvalidate_associations_correlate_ctd_out$plot$logFC.significant\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n`stat_xsidebin()` using `bins = 30`. Pick better value with `binwidth`.\n`stat_ysidebin()` using `bins = 30`. Pick better value with `binwidth`.\n```\n\n\n:::\n\n```{.r .cell-code .hidden}\n#| label: fig-ctd-correlation\n#| layout-ncol: 2\n#| fig-cap: Inter- and intra-dataset validation across the different CellTypeDataset (CTD) and developmental stages. Correlations are computed using Pearson's correlation coefficient. Point density is plotted using a 2D kernel density estimate.\n#| fig-subcap:\n#| - Correlation between the uncorrected p-values from all phenotype-cell type association tests using the Descartes Human vs. Human Cell Landscape CTDs.\n#| - Correlation between the $log_{10}(fold-change)$ from significant phenotype-cell type association tests ($FDR_{p,c}<0.05$) using the Descartes Human vs. Human Cell Landscape CTDs.\n#| - Correlation between the uncorrected p-values from all phenotype-cell type association tests using the Human Cell Landscape fetal samples vs. Human Cell Landscape adult samples.\n#| - Correlation between the $log_{10}(fold-change)$ from significant phenotype-cell type association tests ($FDR_{p,c}<0.05$) using the Human Cell Landscape fetal samples vs. Human Cell Landscape adult samples.\n\nvalidate_associations_correlate_ctd_out_hcl$plot$p.all\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n`stat_xsidebin()` using `bins = 30`. Pick better value with `binwidth`.\n`stat_ysidebin()` using `bins = 30`. Pick better value with `binwidth`.\n```\n\n\n:::\n\n```{.r .cell-code .hidden}\n#| label: fig-ctd-correlation\n#| layout-ncol: 2\n#| fig-cap: Inter- and intra-dataset validation across the different CellTypeDataset (CTD) and developmental stages. Correlations are computed using Pearson's correlation coefficient. Point density is plotted using a 2D kernel density estimate.\n#| fig-subcap:\n#| - Correlation between the uncorrected p-values from all phenotype-cell type association tests using the Descartes Human vs. Human Cell Landscape CTDs.\n#| - Correlation between the $log_{10}(fold-change)$ from significant phenotype-cell type association tests ($FDR_{p,c}<0.05$) using the Descartes Human vs. Human Cell Landscape CTDs.\n#| - Correlation between the uncorrected p-values from all phenotype-cell type association tests using the Human Cell Landscape fetal samples vs. Human Cell Landscape adult samples.\n#| - Correlation between the $log_{10}(fold-change)$ from significant phenotype-cell type association tests ($FDR_{p,c}<0.05$) using the Human Cell Landscape fetal samples vs. Human Cell Landscape adult samples.\n\nvalidate_associations_correlate_ctd_out_hcl$plot$logFC.significant\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n`stat_xsidebin()` using `bins = 30`. Pick better value with `binwidth`.\n`stat_ysidebin()` using `bins = 30`. Pick better value with `binwidth`.\n```\n\n\n:::\n\n::: {.cell-output-display}\n![Correlation between the uncorrected p-values from all phenotype-cell type association tests using the Descartes Human vs. Human Cell Landscape CTDs.](supplement_files/figure-html/fig-ctd-correlation-1.png){#fig-ctd-correlation-1 width=672}\n:::\n\n::: {.cell-output-display}\n![Correlation between the $log_{10}(fold-change)$ from significant phenotype-cell type association tests ($FDR_{p,c}<0.05$) using the Descartes Human vs. Human Cell Landscape CTDs.](supplement_files/figure-html/fig-ctd-correlation-2.png){#fig-ctd-correlation-2 width=672}\n:::\n\n::: {.cell-output-display}\n![Correlation between the uncorrected p-values from all phenotype-cell type association tests using the Human Cell Landscape fetal samples vs. Human Cell Landscape adult samples.](supplement_files/figure-html/fig-ctd-correlation-3.png){#fig-ctd-correlation-3 width=672}\n:::\n\n::: {.cell-output-display}\n![Correlation between the $log_{10}(fold-change)$ from significant phenotype-cell type association tests ($FDR_{p,c}<0.05$) using the Human Cell Landscape fetal samples vs. Human Cell Landscape adult samples.](supplement_files/figure-html/fig-ctd-correlation-4.png){#fig-ctd-correlation-4 width=672}\n:::\n\nInter- and intra-dataset validation across the different CellTypeDataset (CTD) and developmental stages. Correlations are computed using Pearson's correlation coefficient. Point density is plotted using a 2D kernel density estimate.\n:::\n\n::: {.cell}\n\n```{.r .cell-code .hidden}\n#### Filter results with prioritisation pipeline ####\nprioritise_targets_out <- MSTExplorer::prioritise_targets(\n  results = results, \n  ctd_list = ctd_list,\n  \n  keep_deaths=NULL,\n  keep_onsets=NULL,\n  keep_specificity_quantiles = seq(30,40), # NULL:70, 30-40:64 \n  keep_mean_exp_quantiles = seq(30,40), # NULL:65, 10:55\n  info_content_threshold=8, # 8:55, 5:64 \n  effect_threshold=NULL, # 1:39\n  severity_score_gpt_threshold=NULL, # 10:78, NULL:82\n  symptom_intersection_threshold=.25, # .25:57\n  evidence_score_threshold=3,  # 5:47, 4:47, 3:64\n  top_n = 10, # 5:38, 20:42, 30:45, 40:52, 50:55\n  group_vars = \"hpo_id\")\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: phenotype_to_genes.txt\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritising gene targets.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nlogFC already exists in results. Use `force_new=TRUE` to overwrite.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAdding term definitions.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAdding information_content scores.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAnnotating phenos with Disease\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: phenotype.hpoa\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='start' \n - Rows: 51,874,984 \n - Phenotypes: 11,028 \n - Diseases: 12,467 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nFiltering @ q-value <= 0.05\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='q_threshold' \n - Rows: 2,115,670 \n - Phenotypes: 9,575 \n - Diseases: 12,467 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='effect_threshold' \n - Rows: 2,115,670 \n - Phenotypes: 9,575 \n - Diseases: 12,467 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAnnotating phenos with AgeOfDeath.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='keep_deaths' \n - Rows: 2,115,670 \n - Phenotypes: 9,575 \n - Diseases: 12,467 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAdding level-2 ancestor to each HPO ID.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAdding ancestor metadata.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAncestor metadata already present. Use force_new=TRUE to overwrite.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nTranslating ontology terms to ids.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nKeeping descendants of 1 term(s).\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n17,548 terms remain after filtering.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n1,889,042 associations remain after filtering.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='keep_descendants' \n - Rows: 1,889,042 \n - Phenotypes: 9,499 \n - Diseases: 12,364 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nGetting absolute ontology level for 18,082 IDs.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='keep_ont_levels' \n - Rows: 1,889,042 \n - Phenotypes: 9,499 \n - Diseases: 12,364 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nTranslating ontology terms to ids.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: phenotype_to_genes.txt\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n151 phenotypes do not have matching HPO IDs.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading in GPT annotations for 16,982 phenotypes.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='gpt_filters' \n - Rows: 1,889,042 \n - Phenotypes: 9,499 \n - Diseases: 12,364 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='severity_score_gpt_threshold' \n - Rows: 1,889,042 \n - Phenotypes: 9,499 \n - Diseases: 12,364 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='info_content_threshold' \n - Rows: 979,360 \n - Phenotypes: 7,691 \n - Diseases: 11,916 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAnnotating phenos with onset.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='keep_onsets' \n - Rows: 979,360 \n - Phenotypes: 7,691 \n - Diseases: 11,916 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAnnotating phenos with Tiers.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='keep_tiers' \n - Rows: 979,360 \n - Phenotypes: 7,691 \n - Diseases: 11,916 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAnnotating phenos with modifiers\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='severity_threshold' \n - Rows: 979,435 \n - Phenotypes: 7,691 \n - Diseases: 11,916 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='severity_threshold_max' \n - Rows: 979,435 \n - Phenotypes: 7,691 \n - Diseases: 11,916 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAnnotating phenos with n_diseases\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: phenotype_to_genes.txt\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: genes_to_phenotype.txt\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: phenotype.hpoa\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='pheno_ndiseases_threshold' \n - Rows: 979,435 \n - Phenotypes: 7,691 \n - Diseases: 11,916 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAnnotating phenotype frequencies.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='pheno_frequency_threshold' \n - Rows: 981,649 \n - Phenotypes: 7,691 \n - Diseases: 11,916 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='keep_celltypes' \n - Rows: 981,649 \n - Phenotypes: 7,691 \n - Diseases: 11,916 \n - Cell types: 201\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nConverting phenos to GRanges.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nLoading required namespace: ensembldb\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nGathering metadata for 4926 unique genes.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nLoading required namespace: EnsDb.Hsapiens.v75\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='symptom_gene_overlap' \n - Rows: 1,092,098 \n - Phenotypes: 7,015 \n - Diseases: 8,102 \n - Cell types: 201 \n - Genes: 4,650\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nFiltering by keep_chr.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='keep_chr' \n - Rows: 1,092,098 \n - Phenotypes: 7,015 \n - Diseases: 8,102 \n - Cell types: 201 \n - Genes: 4,650\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nFiltering by gene-disease association evidence.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAnnotating gene-disease associations with Evidence Score\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nGathering data from GenCC.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nImporting cached file.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nEvidence scores for: \n - 10390 diseases \n - 5142 genes\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: 2024-03-01\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='evidence_score_threshold' \n - Rows: 825,255 \n - Phenotypes: 6,605 \n - Diseases: 6,622 \n - Cell types: 201 \n - Genes: 3,938\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nFiltering by gene size.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n3,938 / 3,938 genes kept.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='gene_size' \n - Rows: 825,255 \n - Phenotypes: 6,605 \n - Diseases: 6,622 \n - Cell types: 201 \n - Genes: 3,938\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='keep_biotypes' \n - Rows: 825,255 \n - Phenotypes: 6,605 \n - Diseases: 6,622 \n - Cell types: 201 \n - Genes: 3,938\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: phenotype_to_genes.txt\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='add_driver_genes' \n - Rows: 255,497 \n - Phenotypes: 6,447 \n - Diseases: 6,442 \n - Cell types: 201 \n - Genes: 3,873\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAdding symptom-level results.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nSubsetting results by q_threshold and effect.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n255,497 associations remain after filtering.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: phenotype_to_genes.txt\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='symptom_intersection_threshold' \n - Rows: 255,497 \n - Phenotypes: 6,447 \n - Diseases: 6,442 \n - Cell types: 201 \n - Genes: 3,873\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAnnotating gene frequencies.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: genes_to_phenotype.txt\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='gene_frequency_threshold' \n - Rows: 350,367 \n - Phenotypes: 6,447 \n - Diseases: 6,442 \n - Cell types: 201 \n - Genes: 3,873\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPruning ancestors.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n5287 / 6447 terms were kept after pruning.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='prune_ancestors' \n - Rows: 196,856 \n - Phenotypes: 5,287 \n - Diseases: 6,147 \n - Cell types: 201 \n - Genes: 3,774\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nSorting rows.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nFinding top 10 gene targets per: hpo_id\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='top_n' \n - Rows: 32,735 \n - Phenotypes: 5,287 \n - Diseases: 4,850 \n - Cell types: 201 \n - Genes: 3,180\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nPrioritised targets: step='end' \n - Rows: 32,735 \n - Phenotypes: 5,287 \n - Diseases: 4,850 \n - Cell types: 201 \n - Genes: 3,180\n```\n\n\n:::\n:::\n\n\n::: {#fig-diagram}\n![](figures/fig-diagram.png)\n\nDiagrammatic overview of multi-scale disease investigation strategy. Here we provide an abstract example of differential disease aetiology across multiple scales: diseases ($D$), phenotypes ($P$), cell types ($C$), genes ($G$), and clinical outcomes ($O$). In the HPO, genes are assigned to phenotypes via particular diseases ($G_{d,p}$). Therefore, the final gene list for each phenotype is aggregated from across multiple diseases ($G_{p}$). We performed association tests for all pairwise combinations of cell types and phenotypes and filtered results after multiple testing corrections ($FDR_{p,c}<0.05$). Each phenotype in the context of a given disease is referred to here as a symptom. Links were established between symptoms and cell types through proportional gene set overlap at a minimum threshold of 25%.\n:::\n\n\n::: {.cell}\n\n```{.r .cell-code .hidden}\n### Generate filtering report plot\nplot_report_out <- MSTExplorer::plot_report(\n  results = results,\n  rep_dt = prioritise_targets_out$report,\n  show_plot = FALSE,\n  height=10,\n  width=15,\n  save_path = here::here(\"inst/pages/chapter1/figures/fig-therapy-filter.pdf\"))\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nplot_report:: Preparing data.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: phenotype.hpoa\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: phenotype_to_genes.txt\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nplot_report:: Preparing plot.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nSaving plot ==> /Users/bms20/Desktop/Rare Disease Celltyping/rare_disease_celltyping/inst/pages/chapter1/figures/fig-therapy-filter.pdf\n```\n\n\n:::\n:::\n\n::: {#fig-therapy-filter .cell}\n\n```{.r .cell-code .hidden}\n#| label: fig-therapy-filter\n#| fig-cap: Therapeutics - Prioritised target filtering steps.\n#| fig-subcap: This plot visualises the number of unique phenotype-cell type associations, cell types, genes, and phenotypes (*y-axis*) at each filtering step (*x-axis*) within the multi-scale therapeutic target prioritisation pipeline. Each step in the pipeline can be easily adjusted according to user preference and use case. See [**Methods**](#methods) for descriptions and criterion of each filtering step.**a**, The percentage of phenotypes belonging to each severity Tier after each filtering step (Tier 1 being the most severe). **b**, The number of phenotypes, cell types, associated diseases and genes remaining after each filtering step during the gene prioritisation pipeline.\n\nplot_report_out\n```\n\n::: {.cell-output-display}\n![This plot visualises the number of unique phenotype-cell type associations, cell types, genes, and phenotypes (*y-axis*) at each filtering step (*x-axis*) within the multi-scale therapeutic target prioritisation pipeline. Each step in the pipeline can be easily adjusted according to user preference and use case. See [**Methods**](#methods) for descriptions and criterion of each filtering step.**a**, The percentage of phenotypes belonging to each severity Tier after each filtering step (Tier 1 being the most severe). **b**, The number of phenotypes, cell types, associated diseases and genes remaining after each filtering step during the gene prioritisation pipeline.](supplement_files/figure-html/fig-therapy-filter-1.png){#fig-therapy-filter width=1440}\n:::\n\nTherapeutics - Prioritised target filtering steps.\n:::\n\n::: {#cell-fig-monarch-recall .cell}\n\n```{.r .cell-code .hidden}\n#| label: fig-monarch-recall\n#| fig-cap: Recall of Monarch Knowledge Graph phenotype-cell type relationships.\n\ncat(\"!!!RECOMPUTE!!!\")\n```\n\n::: {.cell-output .cell-output-stdout}\n\n```\n!!!RECOMPUTE!!!\n```\n\n\n:::\n:::\n\n::: {#fig-therapy-validate-all .cell}\n\n```{.r .cell-code .hidden}\n#| label: fig-therapy-validate-all\n#| fig-cap: Therapeutics - Validation of prioritised therapeutic targets.\n#| fig-subcap: Proportion of existing all therapy targets (documented in the  Therapeutic Target Database) recapitulated by our prioritisation pipeline.\n\n## All therapy types\nttd_check_all_out <- MSTExplorer::ttd_check(\n  top_targets=prioritise_targets_out$top_targets,   \n  allow.cartesian = TRUE,\n  show_plot = FALSE,\n  save_path = here::here(\"inst/pages/chapter1/figures/fig-therapy-validate-all.pdf\"))\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nLoading required namespace: readxl\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nRetrieving all organisms available in gprofiler.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nUsing stored `gprofiler_orgs`.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nMapping species name: hsapiens\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n1 organism identified from search: hsapiens\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n35,812 / 51,339 (69.76%) genes mapped.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nReading cached RDS file: phenotype_to_genes.txt\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n+ Version: v2024-02-08\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nNon-failed gene targets enrichment p-value: 3.05778572878398e-19\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nFailed gene targets depletion p-value: 2.51631585215379e-199\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nWarning in ggplot2::geom_text(data = unique(dat_sub[, c(\"HIGHEST_STATUS\", : Ignoring unknown aesthetics: fill\nIgnoring unknown aesthetics: fill\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nSaving plot --> /Users/bms20/Desktop/Rare Disease Celltyping/rare_disease_celltyping/inst/pages/chapter1/figures/fig-therapy-validate-all.pdf\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nSaving 8 x 5 in image\n```\n\n\n:::\n\n```{.r .cell-code .hidden}\n#| label: fig-therapy-validate-all\n#| fig-cap: Therapeutics - Validation of prioritised therapeutic targets.\n#| fig-subcap: Proportion of existing all therapy targets (documented in the  Therapeutic Target Database) recapitulated by our prioritisation pipeline.\n\nttd_check_all_out$plot\n```\n\n::: {.cell-output-display}\n![Proportion of existing all therapy targets (documented in the  Therapeutic Target Database) recapitulated by our prioritisation pipeline.](supplement_files/figure-html/fig-therapy-validate-all-1.png){#fig-therapy-validate-all width=768}\n:::\n\nTherapeutics - Validation of prioritised therapeutic targets.\n:::\n\n::: {#fig-animal-models .cell}\n\n```{.r .cell-code .hidden}\n#| label: fig-animal-models\n#| fig-cap:  Identification of translatable experimental models.\n#| fig-subcap: Interspecies translatability of human phenotypes nominated by our gene therapy prioritised pipeline. Above, our combined ontological-genotypic similarity score ($SIM_{o,g}$) is displayed as the heatmap fill colour stratified by the model organism (*x-axis*). An additional column (“n_genes_db1” on the far left) displays the total number of unique genes annotated to the phenotypic within the HPO. Phenotypes are clustered according to their ontological similarity in the HPO (*y-axis*).\n\nlibrary(ggplot2) # <-- Necessary due to bug in one of the plotting dependencies \n\ntop_ids <- unique(prioritise_targets_out$top_targets$hpo_id)[1:1000]\npheno_map_genes_match <- KGExplorer::map_upheno_data()\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nImporting cached data: /Users/bms20/Library/Caches/org.R-project.R/R/KGExplorer/pheno_map_genes_match.rds\n```\n\n\n:::\n\n```{.r .cell-code .hidden}\n#| label: fig-animal-models\n#| fig-cap:  Identification of translatable experimental models.\n#| fig-subcap: Interspecies translatability of human phenotypes nominated by our gene therapy prioritised pipeline. Above, our combined ontological-genotypic similarity score ($SIM_{o,g}$) is displayed as the heatmap fill colour stratified by the model organism (*x-axis*). An additional column (“n_genes_db1” on the far left) displays the total number of unique genes annotated to the phenotypic within the HPO. Phenotypes are clustered according to their ontological similarity in the HPO (*y-axis*).\n\nplot_upheno_out <- KGExplorer::plot_upheno(\n  pheno_map_genes_match = pheno_map_genes_match, \n  filters=list(id1=top_ids)\n  )\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nFiltered 'id1' : 883 / 987 rows dropped.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\n3 / 4 species remain after filtering by `subset_db1`.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nLoading required namespace: ggdist\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nLoading required namespace: tidyquant\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nRegistered S3 method overwritten by 'quantmod':\n  method            from\n  as.zoo.data.frame zoo \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAdding ancestor metadata.\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nLoading cached ontology: /Users/bms20/Library/Caches/org.R-project.R/R/KGExplorer/upheno.rds\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nAncestor metadata already present. Use force_new=TRUE to overwrite.\n```\n\n\n:::\n\n```{.r .cell-code .hidden}\n#| label: fig-animal-models\n#| fig-cap:  Identification of translatable experimental models.\n#| fig-subcap: Interspecies translatability of human phenotypes nominated by our gene therapy prioritised pipeline. Above, our combined ontological-genotypic similarity score ($SIM_{o,g}$) is displayed as the heatmap fill colour stratified by the model organism (*x-axis*). An additional column (“n_genes_db1” on the far left) displays the total number of unique genes annotated to the phenotypic within the HPO. Phenotypes are clustered according to their ontological similarity in the HPO (*y-axis*).\n\nKGExplorer::plot_save(save_path = here::here(\"inst/pages/chapter1/figures/fig-animal-models\"),\n                      plt = plot_upheno_out$heatmap,\n                      width=12, height=9)\n```\n\n::: {.cell-output .cell-output-stderr .hidden}\n\n```\nSaving plot --> /Users/bms20/Desktop/Rare Disease Celltyping/rare_disease_celltyping/inst/pages/chapter1/figures/fig-animal-models\n```\n\n\n:::\n\n```{.r .cell-code .hidden}\n#| label: fig-animal-models\n#| fig-cap:  Identification of translatable experimental models.\n#| fig-subcap: Interspecies translatability of human phenotypes nominated by our gene therapy prioritised pipeline. Above, our combined ontological-genotypic similarity score ($SIM_{o,g}$) is displayed as the heatmap fill colour stratified by the model organism (*x-axis*). An additional column (“n_genes_db1” on the far left) displays the total number of unique genes annotated to the phenotypic within the HPO. Phenotypes are clustered according to their ontological similarity in the HPO (*y-axis*).\n\nplot_upheno_out$heatmap\n```\n\n::: {.cell-output-display}\n![Interspecies translatability of human phenotypes nominated by our gene therapy prioritised pipeline. Above, our combined ontological-genotypic similarity score ($SIM_{o,g}$) is displayed as the heatmap fill colour stratified by the model organism (*x-axis*). An additional column (“n_genes_db1” on the far left) displays the total number of unique genes annotated to the phenotypic within the HPO. Phenotypes are clustered according to their ontological similarity in the HPO (*y-axis*).](supplement_files/figure-html/fig-animal-models-1.png){#fig-animal-models width=960}\n:::\n\nIdentification of translatable experimental models.\n:::\n\n::: {#fig-therapy-examples-supp .cell layout=\"[[1,1],[1,1]]\"}\n\n```{.r .cell-code .hidden}\n#| label: fig-therapy-examples-supp\n#| layout: [[1,1], [1,1]]\n#| fig-cap: Example cell type-specific gene therapy targets for several severe phenotypes and their associated diseases. Each disease (blue cylinders) is connected to its phenotype (purple cylinders) based on well-established clinical observations recorded within the HPO [@Gargano2024-fc].Phenotypes are connected to cell types (red circles) via association testing between weighted gene sets ($FDR_{p,c}<0.05$). Each cell type is connected to the prioritised gene targets (yellow boxes) based on the driver gene analysis.The thickness of the edges connecting the nodes represent the (mean) fold-change from the bootstrapped enrichment tests. Nodes were spatially arranged using the Sugiyama algorithm [@Sugiyama1981-ev].\n#| fig-subcap:\n#| - 'Respiratory failure'\n#| - 'Alzheimer disease'\n#| - 'Parkinson disease'\n\ntop_targets <- prioritise_targets_out$top_targets[,n_genes:=data.table::uniqueN(gene_symbol),\n                                                  by=\"hpo_id\"][n_genes<5 & proportion_driver_genes_symptom>.25]\n\nheight <- \"60vh\"\n\nphenotype <- \"respiratory failure\"\nvn_therapy_eg1 <- MSTExplorer::prioritise_targets_network(\n  top_targets = top_targets[grepl(paste(phenotype,collapse = \"|\"), disease_name,ignore.case = TRUE)],\n  main = phenotype, \n  height = height,\n  submain = NULL)\n```\n\n```\nlogFC already exists in results. Use `force_new=TRUE` to overwrite.\n```\n\n```\nCell type columns already present. Skipping mapping.\n```\n\n```\nCreating network.\n```\n\n```\nMaking hoverboxes from: 'node', 'node_type', 'q', 'CellType', 'ancestor_name', 'disease_id', 'ontLvl', 'definition', 'hpo_name', 'hpo_id', 'disease_name', 'shape', 'name'\n```\n\n```\nAdding hoverboxes to data.table.\n```\n\n```\nLoading required namespace: visNetwork\n```\n\n```\nCreating visNetwork plot.\n```\n\n```\n'title' column already exists. Skipping hoverbox creation.\n```\n\n```\nUsing palette: kovesi.linear_bmy_10_95_c78\n```\n\n```\nWarning in\nvisNetwork::visOptions(visNetwork::visInteraction(visNetwork::visEdges(visNetwork::visNodes(visNetwork::visPhysics(visNetwork::visIgraphLayout(visNetwork::toVisNetworkData(g)\n%>% : Can't find 'name' in node data.frame\n```\n\n```\nSaving plot --> /var/folders/rd/rbc_wrdj4k3djf3brk6z0_dc0000gp/T//RtmpZec0b5/file5922547da26d_prioritise_targets_network.html\n```\n\n```{.r .cell-code .hidden}\n#| label: fig-therapy-examples-supp\n#| layout: [[1,1], [1,1]]\n#| fig-cap: Example cell type-specific gene therapy targets for several severe phenotypes and their associated diseases. Each disease (blue cylinders) is connected to its phenotype (purple cylinders) based on well-established clinical observations recorded within the HPO [@Gargano2024-fc].Phenotypes are connected to cell types (red circles) via association testing between weighted gene sets ($FDR_{p,c}<0.05$). Each cell type is connected to the prioritised gene targets (yellow boxes) based on the driver gene analysis.The thickness of the edges connecting the nodes represent the (mean) fold-change from the bootstrapped enrichment tests. Nodes were spatially arranged using the Sugiyama algorithm [@Sugiyama1981-ev].\n#| fig-subcap:\n#| - 'Respiratory failure'\n#| - 'Alzheimer disease'\n#| - 'Parkinson disease'\n\nphenotype <- \"amyotrophic lateral sclerosis\"\nvn_therapy_eg2 <- MSTExplorer::prioritise_targets_network(\n  top_targets = top_targets[grepl(paste(phenotype,collapse = \"|\"), disease_name,ignore.case = TRUE)],\n  main = phenotype,\n  height = height,\n  submain = NULL)\n```\n\n```\nlogFC already exists in results. Use `force_new=TRUE` to overwrite.\n```\n\n```\nCell type columns already present. Skipping mapping.\n```\n\n```\nCreating network.\n```\n\n```\nMaking hoverboxes from: 'node', 'node_type', 'q', 'CellType', 'ancestor_name', 'disease_id', 'ontLvl', 'definition', 'hpo_name', 'hpo_id', 'disease_name', 'shape', 'name'\n```\n\n```\nAdding hoverboxes to data.table.\n```\n\n```\nCreating visNetwork plot.\n```\n\n```\n'title' column already exists. Skipping hoverbox creation.\n```\n\n```\nUsing palette: kovesi.linear_bmy_10_95_c78\n```\n\n```\nWarning in\nvisNetwork::visOptions(visNetwork::visInteraction(visNetwork::visEdges(visNetwork::visNodes(visNetwork::visPhysics(visNetwork::visIgraphLayout(visNetwork::toVisNetworkData(g)\n%>% : Can't find 'name' in node data.frame\n```\n\n```\nSaving plot --> /var/folders/rd/rbc_wrdj4k3djf3brk6z0_dc0000gp/T//RtmpZec0b5/file5922234db7de_prioritise_targets_network.html\n```\n\n```{.r .cell-code .hidden}\n#| label: fig-therapy-examples-supp\n#| layout: [[1,1], [1,1]]\n#| fig-cap: Example cell type-specific gene therapy targets for several severe phenotypes and their associated diseases. Each disease (blue cylinders) is connected to its phenotype (purple cylinders) based on well-established clinical observations recorded within the HPO [@Gargano2024-fc].Phenotypes are connected to cell types (red circles) via association testing between weighted gene sets ($FDR_{p,c}<0.05$). Each cell type is connected to the prioritised gene targets (yellow boxes) based on the driver gene analysis.The thickness of the edges connecting the nodes represent the (mean) fold-change from the bootstrapped enrichment tests. Nodes were spatially arranged using the Sugiyama algorithm [@Sugiyama1981-ev].\n#| fig-subcap:\n#| - 'Respiratory failure'\n#| - 'Alzheimer disease'\n#| - 'Parkinson disease'\n\nphenotype <- \"neurodegeneration\"\nvn_therapy_eg3 <- MSTExplorer::prioritise_targets_network(\n  top_targets = top_targets[grepl(paste(phenotype,collapse = \"|\"), disease_name,ignore.case = TRUE)], \n  main = phenotype, \n  height = height,\n  submain = NULL)\n```\n\n```\nlogFC already exists in results. Use `force_new=TRUE` to overwrite.\n```\n\n```\nCell type columns already present. Skipping mapping.\n```\n\n```\nCreating network.\n```\n\n```\nMaking hoverboxes from: 'node', 'node_type', 'q', 'CellType', 'ancestor_name', 'disease_id', 'ontLvl', 'definition', 'hpo_name', 'hpo_id', 'disease_name', 'shape', 'name'\n```\n\n```\nAdding hoverboxes to data.table.\n```\n\n```\nCreating visNetwork plot.\n```\n\n```\n'title' column already exists. Skipping hoverbox creation.\n```\n\n```\nUsing palette: kovesi.linear_bmy_10_95_c78\n```\n\n```\nWarning in\nvisNetwork::visOptions(visNetwork::visInteraction(visNetwork::visEdges(visNetwork::visNodes(visNetwork::visPhysics(visNetwork::visIgraphLayout(visNetwork::toVisNetworkData(g)\n%>% : Can't find 'name' in node data.frame\n```\n\n```\nSaving plot --> /var/folders/rd/rbc_wrdj4k3djf3brk6z0_dc0000gp/T//RtmpZec0b5/file5922700b312a_prioritise_targets_network.html\n```\n\n```{.r .cell-code .hidden}\n#| label: fig-therapy-examples-supp\n#| layout: [[1,1], [1,1]]\n#| fig-cap: Example cell type-specific gene therapy targets for several severe phenotypes and their associated diseases. Each disease (blue cylinders) is connected to its phenotype (purple cylinders) based on well-established clinical observations recorded within the HPO [@Gargano2024-fc].Phenotypes are connected to cell types (red circles) via association testing between weighted gene sets ($FDR_{p,c}<0.05$). Each cell type is connected to the prioritised gene targets (yellow boxes) based on the driver gene analysis.The thickness of the edges connecting the nodes represent the (mean) fold-change from the bootstrapped enrichment tests. Nodes were spatially arranged using the Sugiyama algorithm [@Sugiyama1981-ev].\n#| fig-subcap:\n#| - 'Respiratory failure'\n#| - 'Alzheimer disease'\n#| - 'Parkinson disease'\n\nphenotype <- \"small vessel disease\"\nvn_therapy_eg4 <- MSTExplorer::prioritise_targets_network(\n  top_targets = top_targets[grepl(paste(phenotype,collapse = \"|\"), disease_name,ignore.case = TRUE)], \n  main = phenotype, \n  height = height,\n  submain = NULL)\n```\n\n```\nlogFC already exists in results. Use `force_new=TRUE` to overwrite.\n```\n\n```\nCell type columns already present. Skipping mapping.\n```\n\n```\nCreating network.\n```\n\n```\nMaking hoverboxes from: 'node', 'node_type', 'q', 'CellType', 'ancestor_name', 'disease_id', 'ontLvl', 'definition', 'hpo_name', 'hpo_id', 'disease_name', 'shape', 'name'\n```\n\n```\nAdding hoverboxes to data.table.\n```\n\n```\nCreating visNetwork plot.\n```\n\n```\n'title' column already exists. Skipping hoverbox creation.\n```\n\n```\nUsing palette: kovesi.linear_bmy_10_95_c78\n```\n\n```\nWarning in\nvisNetwork::visOptions(visNetwork::visInteraction(visNetwork::visEdges(visNetwork::visNodes(visNetwork::visPhysics(visNetwork::visIgraphLayout(visNetwork::toVisNetworkData(g)\n%>% : Can't find 'name' in node data.frame\n```\n\n```\nSaving plot --> /var/folders/rd/rbc_wrdj4k3djf3brk6z0_dc0000gp/T//RtmpZec0b5/file59224b85b8fd_prioritise_targets_network.html\n```\n\n```{.r .cell-code .hidden}\n#| label: fig-therapy-examples-supp\n#| layout: [[1,1], [1,1]]\n#| fig-cap: Example cell type-specific gene therapy targets for several severe phenotypes and their associated diseases. Each disease (blue cylinders) is connected to its phenotype (purple cylinders) based on well-established clinical observations recorded within the HPO [@Gargano2024-fc].Phenotypes are connected to cell types (red circles) via association testing between weighted gene sets ($FDR_{p,c}<0.05$). Each cell type is connected to the prioritised gene targets (yellow boxes) based on the driver gene analysis.The thickness of the edges connecting the nodes represent the (mean) fold-change from the bootstrapped enrichment tests. Nodes were spatially arranged using the Sugiyama algorithm [@Sugiyama1981-ev].\n#| fig-subcap:\n#| - 'Respiratory failure'\n#| - 'Alzheimer disease'\n#| - 'Parkinson disease'\n\nvn_therapy_eg1$plot\n```\n\n```{=html}\n<div id=\"htmlwidget-1d265e30742baf1dfe20\" style=\"width:100%;height:60vh;\" class=\"visNetwork html-widget\"></div>\n<script type=\"application/json\" data-for=\"htmlwidget-1d265e30742baf1dfe20\">{\"x\":{\"nodes\":{\"id\":[\"Neurodegeneration\\nwith\\ndevelopmental\\ndelay,\\nearly\\nrespiratory\\nfailure,\\nmyoclonic\\nseizures,\\nand brain\\nabnormalities\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Dysgyria\",\"Necrotizing\\nmyopathy\",\"Internally\\nnucleated\\nskeletal\\nmuscle\\nfibers\",\"Tibialis\\nmuscle\\nweakness\",\"Hypertrophied\\nmuscle\\nfibers\",\"embryonic\\nstem cell\",\"cell of\\nskeletal\\nmuscle\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"cardiac\\nmuscle\\ncell\",\"regular\\natrial\\ncardiac\\nmyocyte\",\"MED11\",\"TTN\"],\"node\":[\"Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities\",\"Hereditary myopathy with early respiratory failure\",\"Dysgyria\",\"Necrotizing myopathy\",\"Internally nucleated skeletal muscle fibers\",\"Tibialis muscle weakness\",\"Hypertrophied muscle fibers\",\"embryonic stem cell\",\"cell of skeletal muscle\",\"ventricular cardiac muscle cell\",\"cardiac muscle cell\",\"regular atrial cardiac myocyte\",\"MED11\",\"TTN\"],\"node_type\":[\"disease_name\",\"disease_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"gene_symbol\",\"gene_symbol\"],\"q\":[0.00982812955879336,3.903200397061551e-15,0.00982812955879336,3.903200397061551e-15,1.00810902139222e-14,3.87556565479797e-06,2.26585231573316e-23,0.00982812955879336,3.903200397061551e-15,6.772739823054781e-08,5.086330644754479e-11,1.62095250281668e-07,0.00982812955879336,3.903200397061551e-15],\"CellType\":[\"Adult_hESC\",\"Skeletal_muscle_cells\",\"Adult_hESC\",\"Skeletal_muscle_cells\",\"Adult_Ventricle_cardiomyocyte\",\"Adult_Ventricle_cardiomyocyte\",\"Adult_Ventricle_cardiomyocyte\",\"Adult_hESC\",\"Skeletal_muscle_cells\",\"Adult_Ventricle_cardiomyocyte\",\"Cardiomyocytes\",\"CLC_IL5RA_positive_cells\",\"Adult_hESC\",\"Skeletal_muscle_cells\"],\"ancestor_name\":[null,null,\"Abnormality of the nervous system\",\"Abnormality of the musculoskeletal system\",\"Abnormality of the musculoskeletal system\",\"Abnormality of the musculoskeletal system\",\"Abnormality of the musculoskeletal system\",null,null,null,null,null,null,null],\"disease_id\":[\"OMIM:620327\",\"ORPHA:178464\",\"OMIM:620327\",\"ORPHA:178464\",\"ORPHA:178464\",\"ORPHA:178464\",\"ORPHA:178464\",\"OMIM:620327\",\"ORPHA:178464\",\"ORPHA:178464\",\"ORPHA:178464\",\"ORPHA:178464\",\"OMIM:620327\",\"ORPHA:178464\"],\"ontLvl\":[null,null,10,6,7,9,6,null,null,null,null,null,null,null],\"definition\":[null,null,\"An abnormal gyral pattern characterized by abnormalities of sulcal depth or orientation.\",null,\"An abnormally increased proportion of nuclei of sarcomeres with an internal localization. Individual muscle fibers are syncytia, formed by embryonic fusion of many myoblasts or later, myosatellite cells. Each muscle fiber contains many nuclei, peripherally positioned immediately adjacent to the sarcolemmal membrane. In healthy muscle only 3-5% of fibers contain nuclei that are located internally, within the cell, but many disease processes lead to internal nuclei.\",\"Muscle weakness affecting the tibialis anterior muscle.\",\"The presence of an increased amount of muscle fibers with an increased diameter. This feature can be ascertained by microscopic examination of a muscle biopsy sample. Together with fiber size variation and atrophied muscle fibers, and hypertrophied muscle fibers are commonly found in myopathies.\",null,null,null,null,null,null,null],\"hpo_name\":[\"Dysgyria\",\"Necrotizing myopathy\",\"Dysgyria\",\"Necrotizing myopathy\",\"Internally nucleated skeletal muscle fibers\",\"Tibialis muscle weakness\",\"Hypertrophied muscle fibers\",\"Dysgyria\",\"Necrotizing myopathy\",\"Necrotizing myopathy\",\"Internally nucleated skeletal muscle fibers\",\"Internally nucleated skeletal muscle fibers\",\"Dysgyria\",\"Necrotizing myopathy\"],\"hpo_id\":[\"HP:0032398\",\"HP:0008978\",\"HP:0032398\",\"HP:0008978\",\"HP:0031237\",\"HP:0008963\",\"HP:0100293\",\"HP:0032398\",\"HP:0008978\",\"HP:0008978\",\"HP:0031237\",\"HP:0031237\",\"HP:0032398\",\"HP:0008978\"],\"disease_name\":[\"Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities\",\"Hereditary myopathy with early respiratory failure\",\"Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities\",\"Hereditary myopathy with early respiratory failure\",\"Hereditary myopathy with early respiratory failure\",\"Hereditary myopathy with early respiratory failure\",\"Hereditary myopathy with early respiratory failure\",\"Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities\",\"Hereditary myopathy with early respiratory failure\",\"Hereditary myopathy with early respiratory failure\",\"Hereditary myopathy with early respiratory failure\",\"Hereditary myopathy with early respiratory failure\",\"Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities\",\"Hereditary myopathy with early respiratory failure\"],\"shape\":[\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"box\",\"box\"],\"title\":[\"<b>node<\\/b>= Neurodegeneration with developmental delay, early\\nrespiratory failure, myoclonic seizures, and brain\\nabnormalities<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0.01<br><b>CellType<\\/b>= Adult_hESC<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620327<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Dysgyria<br><b>hpo_id<\\/b>= HP:0032398<br><b>disease_name<\\/b>= Neurodegeneration with developmental delay, early\\nrespiratory failure, myoclonic seizures, and brain\\nabnormalities<br><b>shape<\\/b>= database<br><b>name<\\/b>= Neurodegeneration with developmental delay, early\\nrespiratory failure, myoclonic seizures, and brain\\nabnormalities<br>\",\"<b>node<\\/b>= Hereditary myopathy with early respiratory failure<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Skeletal_muscle_cells<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= ORPHA:178464<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Necrotizing myopathy<br><b>hpo_id<\\/b>= HP:0008978<br><b>disease_name<\\/b>= Hereditary myopathy with early respiratory failure<br><b>shape<\\/b>= database<br><b>name<\\/b>= Hereditary myopathy with early respiratory failure<br>\",\"<b>node<\\/b>= Dysgyria<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0.01<br><b>CellType<\\/b>= Adult_hESC<br><b>ancestor_name<\\/b>= Abnormality of the nervous system<br><b>disease_id<\\/b>= OMIM:620327<br><b>ontLvl<\\/b>= 10<br><b>definition<\\/b>= An abnormal gyral pattern characterized by abnormalities of\\nsulcal depth or orientation.<br><b>hpo_name<\\/b>= Dysgyria<br><b>hpo_id<\\/b>= HP:0032398<br><b>disease_name<\\/b>= Neurodegeneration with developmental delay, early\\nrespiratory failure, myoclonic seizures, and brain\\nabnormalities<br><b>shape<\\/b>= database<br><b>name<\\/b>= Dysgyria<br>\",\"<b>node<\\/b>= Necrotizing myopathy<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Skeletal_muscle_cells<br><b>ancestor_name<\\/b>= Abnormality of the musculoskeletal system<br><b>disease_id<\\/b>= ORPHA:178464<br><b>ontLvl<\\/b>= 6<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Necrotizing myopathy<br><b>hpo_id<\\/b>= HP:0008978<br><b>disease_name<\\/b>= Hereditary myopathy with early respiratory failure<br><b>shape<\\/b>= database<br><b>name<\\/b>= Necrotizing myopathy<br>\",\"<b>node<\\/b>= Internally nucleated skeletal muscle fibers<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Adult_Ventricle_cardiomyocyte<br><b>ancestor_name<\\/b>= Abnormality of the musculoskeletal system<br><b>disease_id<\\/b>= ORPHA:178464<br><b>ontLvl<\\/b>= 7<br><b>definition<\\/b>= An abnormally increased proportion of nuclei of sarcomeres\\nwith an internal localization. Individual muscle fibers are\\nsyncytia, formed by embryonic fusion of many myoblasts or\\nlater, myosatellite cells. Each muscle fiber contains many\\nnuclei, peripherally positioned immediately adjacent to the\\nsarcolemmal membrane. In healthy muscle only 3-5% of fibers\\ncontain nuclei that are located internally, within the cell,\\nbut many disease processes lead to internal nuclei.<br><b>hpo_name<\\/b>= Internally nucleated skeletal muscle fibers<br><b>hpo_id<\\/b>= HP:0031237<br><b>disease_name<\\/b>= Hereditary myopathy with early respiratory failure<br><b>shape<\\/b>= database<br><b>name<\\/b>= Internally nucleated skeletal muscle fibers<br>\",\"<b>node<\\/b>= Tibialis muscle weakness<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Adult_Ventricle_cardiomyocyte<br><b>ancestor_name<\\/b>= Abnormality of the musculoskeletal system<br><b>disease_id<\\/b>= ORPHA:178464<br><b>ontLvl<\\/b>= 9<br><b>definition<\\/b>= Muscle weakness affecting the tibialis anterior muscle.<br><b>hpo_name<\\/b>= Tibialis muscle weakness<br><b>hpo_id<\\/b>= HP:0008963<br><b>disease_name<\\/b>= Hereditary myopathy with early respiratory failure<br><b>shape<\\/b>= database<br><b>name<\\/b>= Tibialis muscle weakness<br>\",\"<b>node<\\/b>= Hypertrophied muscle fibers<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Adult_Ventricle_cardiomyocyte<br><b>ancestor_name<\\/b>= Abnormality of the musculoskeletal system<br><b>disease_id<\\/b>= ORPHA:178464<br><b>ontLvl<\\/b>= 6<br><b>definition<\\/b>= The presence of an increased amount of muscle fibers with\\nan increased diameter. This feature can be ascertained by\\nmicroscopic examination of a muscle biopsy sample. Together\\nwith fiber size variation and atrophied muscle fibers,\\nand hypertrophied muscle fibers are commonly found in\\nmyopathies.<br><b>hpo_name<\\/b>= Hypertrophied muscle fibers<br><b>hpo_id<\\/b>= HP:0100293<br><b>disease_name<\\/b>= Hereditary myopathy with early respiratory failure<br><b>shape<\\/b>= database<br><b>name<\\/b>= Hypertrophied muscle fibers<br>\",\"<b>node<\\/b>= embryonic stem cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.01<br><b>CellType<\\/b>= Adult_hESC<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620327<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Dysgyria<br><b>hpo_id<\\/b>= HP:0032398<br><b>disease_name<\\/b>= Neurodegeneration with developmental delay, early\\nrespiratory failure, myoclonic seizures, and brain\\nabnormalities<br><b>shape<\\/b>= circle<br><b>name<\\/b>= embryonic stem cell<br>\",\"<b>node<\\/b>= cell of skeletal muscle<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Skeletal_muscle_cells<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= ORPHA:178464<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Necrotizing myopathy<br><b>hpo_id<\\/b>= HP:0008978<br><b>disease_name<\\/b>= Hereditary myopathy with early respiratory failure<br><b>shape<\\/b>= circle<br><b>name<\\/b>= cell of skeletal muscle<br>\",\"<b>node<\\/b>= ventricular cardiac muscle cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Adult_Ventricle_cardiomyocyte<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= ORPHA:178464<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Necrotizing myopathy<br><b>hpo_id<\\/b>= HP:0008978<br><b>disease_name<\\/b>= Hereditary myopathy with early respiratory failure<br><b>shape<\\/b>= circle<br><b>name<\\/b>= ventricular cardiac muscle cell<br>\",\"<b>node<\\/b>= cardiac muscle cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Cardiomyocytes<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= ORPHA:178464<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Internally nucleated skeletal muscle fibers<br><b>hpo_id<\\/b>= HP:0031237<br><b>disease_name<\\/b>= Hereditary myopathy with early respiratory failure<br><b>shape<\\/b>= circle<br><b>name<\\/b>= cardiac muscle cell<br>\",\"<b>node<\\/b>= regular atrial cardiac myocyte<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= CLC_IL5RA_positive_cells<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= ORPHA:178464<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Internally nucleated skeletal muscle fibers<br><b>hpo_id<\\/b>= HP:0031237<br><b>disease_name<\\/b>= Hereditary myopathy with early respiratory failure<br><b>shape<\\/b>= circle<br><b>name<\\/b>= regular atrial cardiac myocyte<br>\",\"<b>node<\\/b>= MED11<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0.01<br><b>CellType<\\/b>= Adult_hESC<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620327<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Dysgyria<br><b>hpo_id<\\/b>= HP:0032398<br><b>disease_name<\\/b>= Neurodegeneration with developmental delay, early\\nrespiratory failure, myoclonic seizures, and brain\\nabnormalities<br><b>shape<\\/b>= box<br><b>name<\\/b>= MED11<br>\",\"<b>node<\\/b>= TTN<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Skeletal_muscle_cells<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= ORPHA:178464<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Necrotizing myopathy<br><b>hpo_id<\\/b>= HP:0008978<br><b>disease_name<\\/b>= Hereditary myopathy with early respiratory failure<br><b>shape<\\/b>= box<br><b>name<\\/b>= TTN<br>\"],\"degree\":[2,24,2,4,6,2,12,3,6,18,6,6,1,12],\"value\":[23,1,23,21,19,23,13,22,19,7,19,19,24,13],\"color\":[\"#000C7D\",\"#000C7D\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FFF123\",\"#FFF123\"],\"label\":[\"Neurodegeneration\\nwith\\ndevelopmental\\ndelay,\\nearly\\nrespiratory\\nfailure,\\nmyoclonic\\nseizures,\\nand brain\\nabnormalities\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Dysgyria\",\"Necrotizing\\nmyopathy\",\"Internally\\nnucleated\\nskeletal\\nmuscle\\nfibers\",\"Tibialis\\nmuscle\\nweakness\",\"Hypertrophied\\nmuscle\\nfibers\",\"embryonic\\nstem cell\",\"cell of\\nskeletal\\nmuscle\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"cardiac\\nmuscle\\ncell\",\"regular\\natrial\\ncardiac\\nmyocyte\",\"MED11\",\"TTN\"],\"x\":[-0.9375,0.125,-1,0.25,0.625,-0.5,0.125,-0.9375,0.75,-0.0625,1,0.4375,-0.9375,0.1875],\"y\":[-1,-1,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,1,1]},\"edges\":{\"from\":[\"Neurodegeneration\\nwith\\ndevelopmental\\ndelay,\\nearly\\nrespiratory\\nfailure,\\nmyoclonic\\nseizures,\\nand brain\\nabnormalities\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Dysgyria\",\"Necrotizing\\nmyopathy\",\"Necrotizing\\nmyopathy\",\"Internally\\nnucleated\\nskeletal\\nmuscle\\nfibers\",\"Internally\\nnucleated\\nskeletal\\nmuscle\\nfibers\",\"Internally\\nnucleated\\nskeletal\\nmuscle\\nfibers\",\"Tibialis\\nmuscle\\nweakness\",\"Hypertrophied\\nmuscle\\nfibers\",\"Hypertrophied\\nmuscle\\nfibers\",\"Hypertrophied\\nmuscle\\nfibers\",\"Hypertrophied\\nmuscle\\nfibers\",\"Hypertrophied\\nmuscle\\nfibers\",\"Hypertrophied\\nmuscle\\nfibers\",\"embryonic\\nstem cell\",\"cell of\\nskeletal\\nmuscle\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"cardiac\\nmuscle\\ncell\",\"regular\\natrial\\ncardiac\\nmyocyte\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"cell of\\nskeletal\\nmuscle\",\"cardiac\\nmuscle\\ncell\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"regular\\natrial\\ncardiac\\nmyocyte\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"Neurodegeneration\\nwith\\ndevelopmental\\ndelay,\\nearly\\nrespiratory\\nfailure,\\nmyoclonic\\nseizures,\\nand brain\\nabnormalities\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\",\"Hereditary\\nmyopathy\\nwith early\\nrespiratory\\nfailure\"],\"to\":[\"Dysgyria\",\"Necrotizing\\nmyopathy\",\"Necrotizing\\nmyopathy\",\"Internally\\nnucleated\\nskeletal\\nmuscle\\nfibers\",\"Internally\\nnucleated\\nskeletal\\nmuscle\\nfibers\",\"Internally\\nnucleated\\nskeletal\\nmuscle\\nfibers\",\"Tibialis\\nmuscle\\nweakness\",\"Hypertrophied\\nmuscle\\nfibers\",\"Hypertrophied\\nmuscle\\nfibers\",\"Hypertrophied\\nmuscle\\nfibers\",\"Hypertrophied\\nmuscle\\nfibers\",\"Hypertrophied\\nmuscle\\nfibers\",\"Hypertrophied\\nmuscle\\nfibers\",\"embryonic\\nstem cell\",\"cell of\\nskeletal\\nmuscle\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"cardiac\\nmuscle\\ncell\",\"regular\\natrial\\ncardiac\\nmyocyte\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"cell of\\nskeletal\\nmuscle\",\"cardiac\\nmuscle\\ncell\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"regular\\natrial\\ncardiac\\nmyocyte\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"MED11\",\"TTN\",\"TTN\",\"TTN\",\"TTN\",\"TTN\",\"TTN\",\"TTN\",\"TTN\",\"TTN\",\"TTN\",\"TTN\",\"TTN\",\"embryonic\\nstem cell\",\"cell of\\nskeletal\\nmuscle\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"cardiac\\nmuscle\\ncell\",\"regular\\natrial\\ncardiac\\nmyocyte\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"cell of\\nskeletal\\nmuscle\",\"cardiac\\nmuscle\\ncell\",\"ventricular\\ncardiac\\nmuscle\\ncell\",\"regular\\natrial\\ncardiac\\nmyocyte\",\"ventricular\\ncardiac\\nmuscle\\ncell\"],\"color\":[0.6688509053236619,1.08954997028472,1.08954997028472,1.076993360592427,1.076993360592427,1.076993360592427,0.8981236900140366,0.9051308351138957,0.9051308351138957,0.9051308351138957,0.9051308351138957,0.9051308351138957,0.9051308351138957,0.6688509053236619,1.19842892794161,0.9806710126278304,1.209037878474736,1.077784378901872,0.9441578244006716,0.8981236900140366,0.9355757174642009,1.080994285654822,0.876188768299805,0.9355757174642009,0.6668748043361445,0.9355757174642009,0.6688509053236619,1.139711606798216,0.9824266222515342,0.9824266222515342,0.9769865736008387,0.8055163143684081,0.9824266222515342,0.9824266222515342,1.139711606798216,0.9769865736008387,0.9824266222515342,0.8055163143684081,0.9824266222515342,0.6688509053236619,1.139711606798216,0.9824266222515342,0.9824266222515342,0.9769865736008387,0.8055163143684081,0.9824266222515342,0.9824266222515342,1.139711606798216,0.9769865736008387,0.9824266222515342,0.8055163143684081,0.9824266222515342],\"width\":[0.6688509053236619,1.19842892794161,0.9806710126278304,1.209037878474736,1.077784378901872,0.9441578244006716,0.8981236900140366,1.399632527536373,1.080994285654822,0.876188768299805,0.7227993800128905,0.6668748043361445,0.6842952448433385,0.6688509053236619,1.19842892794161,0.9806710126278304,1.209037878474736,1.077784378901872,0.9441578244006716,0.8981236900140366,1.399632527536373,1.080994285654822,0.876188768299805,0.7227993800128905,0.6668748043361445,0.6842952448433385,0.6688509053236619,1.19842892794161,0.9806710126278304,1.209037878474736,1.077784378901872,0.9441578244006716,0.8981236900140366,1.399632527536373,1.080994285654822,0.876188768299805,0.7227993800128905,0.6668748043361445,0.6842952448433385,0.6688509053236619,1.19842892794161,0.9806710126278304,1.209037878474736,1.077784378901872,0.9441578244006716,0.8981236900140366,1.399632527536373,1.080994285654822,0.876188768299805,0.7227993800128905,0.6668748043361445,0.6842952448433385]},\"nodesToDataframe\":true,\"edgesToDataframe\":true,\"options\":{\"width\":\"100%\",\"height\":\"100%\",\"nodes\":{\"shape\":\"dot\",\"physics\":false,\"borderWidth\":3,\"borderWidthSelected\":6,\"color\":{\"hover\":{\"background\":\"rgba(0,0,0,.5)\"},\"highlight\":{\"background\":\"#00FFFFCF\",\"border\":\"#00FFFFCF\"}},\"opacity\":0.75,\"font\":{\"color\":\"#F0FFFF\",\"strokeWidth\":2,\"strokeColor\":\"rgba(0,0,0,1)\"},\"shadow\":{\"enabled\":true,\"size\":10}},\"manipulation\":{\"enabled\":false},\"edges\":{\"arrows\":\"from\",\"color\":{\"opacity\":0.5},\"smooth\":{\"enabled\":true,\"type\":\"cubicBezier\",\"roundness\":0.5},\"shadow\":{\"enabled\":false}},\"physics\":{\"solver\":\"forceAtlas2Based\",\"enabled\":false,\"forceAtlas2Based\":{\"avoidOverlap\":0.5,\"gravitationalConstant\":-50}},\"interaction\":{\"hover\":true,\"zoomSpeed\":1}},\"groups\":null,\"width\":\"100%\",\"height\":\"60vh\",\"idselection\":{\"enabled\":false,\"style\":\"width: 150px; height: 26px\",\"useLabels\":true,\"main\":\"Select by id\"},\"byselection\":{\"enabled\":false,\"style\":\"width: 150px; height: 26px\",\"multiple\":false,\"hideColor\":\"rgba(200,200,200,0.5)\",\"highlight\":false,\"variable\":\"name\",\"main\":\"Select by name\"},\"main\":{\"text\":\"respiratory failure\",\"style\":\"font-family:Georgia, Times New Roman, Times, serif;font-weight:bold;font-size:20px;text-align:center;\"},\"submain\":null,\"footer\":null,\"background\":\"transparent\",\"igraphlayout\":{\"type\":\"full\"},\"tooltipStay\":300,\"tooltipStyle\":\"position: fixed;visibility:hidden;padding: 5px;white-space: nowrap;font-family: verdana;font-size:14px;font-color:#000000;background-color: #f5f4ed;-moz-border-radius: 3px;-webkit-border-radius: 3px;border-radius: 3px;border: 1px solid #808074;box-shadow: 3px 3px 10px rgba(0, 0, 0, 0.2);\",\"highlight\":{\"enabled\":true,\"hoverNearest\":false,\"degree\":1,\"algorithm\":\"all\",\"hideColor\":\"rgba(200,200,200,0.5)\",\"labelOnly\":true},\"collapse\":{\"enabled\":false,\"fit\":false,\"resetHighlight\":true,\"clusterOptions\":null,\"keepCoord\":true,\"labelSuffix\":\"(cluster)\"},\"events\":{\"doubleClick\":\"function(){ this.fit()}\"}},\"evals\":[\"events.doubleClick\"],\"jsHooks\":[]}</script>\n```\n\n\nRespiratory failure\n\n```{.r .cell-code .hidden}\n#| label: fig-therapy-examples-supp\n#| layout: [[1,1], [1,1]]\n#| fig-cap: Example cell type-specific gene therapy targets for several severe phenotypes and their associated diseases. Each disease (blue cylinders) is connected to its phenotype (purple cylinders) based on well-established clinical observations recorded within the HPO [@Gargano2024-fc].Phenotypes are connected to cell types (red circles) via association testing between weighted gene sets ($FDR_{p,c}<0.05$). Each cell type is connected to the prioritised gene targets (yellow boxes) based on the driver gene analysis.The thickness of the edges connecting the nodes represent the (mean) fold-change from the bootstrapped enrichment tests. Nodes were spatially arranged using the Sugiyama algorithm [@Sugiyama1981-ev].\n#| fig-subcap:\n#| - 'Respiratory failure'\n#| - 'Alzheimer disease'\n#| - 'Parkinson disease'\n\nvn_therapy_eg2$plot\n```\n\n```{=html}\n<div id=\"htmlwidget-45c3c5c5d12162273397\" style=\"width:100%;height:60vh;\" class=\"visNetwork html-widget\"></div>\n<script type=\"application/json\" data-for=\"htmlwidget-45c3c5c5d12162273397\">{\"x\":{\"nodes\":{\"id\":[\"Amyotrophic\\nlateral\\nsclerosis\\n4,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis\\n27,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis\\n2,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis,\\nsusceptibility\\nto, 24\",\"Pallor\\nof dorsal\\ncolumns of\\nthe spinal\\ncord\",\"Diffuse\\naxonal\\nswelling\",\"Angulated\\nmuscle\\nfibers\",\"Difficulty\\nin tongue\\nmovements\",\"Hippocampal\\natrophy\",\"acinar\\ncell\",\"fibroblast\",\"neuron\",\"epithelial\\ncell of\\nproximal\\ntubule\",\"Purkinje\\ncell\",\"SETX\",\"SPTLC1\",\"ALS2\",\"NEK1\"],\"node\":[\"Amyotrophic lateral sclerosis 4, juvenile\",\"Amyotrophic lateral sclerosis 27, juvenile\",\"Amyotrophic lateral sclerosis 2, juvenile\",\"Amyotrophic lateral sclerosis, susceptibility to, 24\",\"Pallor of dorsal columns of the spinal cord\",\"Diffuse axonal swelling\",\"Angulated muscle fibers\",\"Difficulty in tongue movements\",\"Hippocampal atrophy\",\"acinar cell\",\"fibroblast\",\"neuron\",\"epithelial cell of proximal tubule\",\"Purkinje cell\",\"SETX\",\"SPTLC1\",\"ALS2\",\"NEK1\"],\"node_type\":[\"disease_name\",\"disease_name\",\"disease_name\",\"disease_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"gene_symbol\",\"gene_symbol\",\"gene_symbol\",\"gene_symbol\"],\"q\":[1.96376162830803e-13,0.000805395007424179,8.01795135201007e-05,1.1700111368914e-11,1.96376162830803e-13,1.81616698309387e-11,0.000805395007424179,8.01795135201007e-05,1.1700111368914e-11,1.96376162830803e-13,0.000805395007424179,0.021582455012171,8.01795135201007e-05,0.00227227346810646,1.96376162830803e-13,0.000805395007424179,8.01795135201007e-05,1.1700111368914e-11],\"CellType\":[\"Adult_Fetal_acinar_cell\",\"Adult_Fetal_fibroblast\",\"Fetus_Proximal_tubule_progenitor\",\"SLC24A4_PEX5L_positive_cells\",\"Adult_Fetal_acinar_cell\",\"Adult_Fetal_acinar_cell\",\"Adult_Fetal_fibroblast\",\"Fetus_Proximal_tubule_progenitor\",\"SLC24A4_PEX5L_positive_cells\",\"Adult_Fetal_acinar_cell\",\"Adult_Fetal_fibroblast\",\"Adult_Fetal_Neuron\",\"Fetus_Proximal_tubule_progenitor\",\"Purkinje_neurons\",\"Adult_Fetal_acinar_cell\",\"Adult_Fetal_fibroblast\",\"Fetus_Proximal_tubule_progenitor\",\"SLC24A4_PEX5L_positive_cells\"],\"ancestor_name\":[null,null,null,null,\"Abnormality of the nervous system\",\"Abnormality of the nervous system\",\"Abnormality of the musculoskeletal system\",\"Abnormality of head or neck\",\"Abnormality of the nervous system\",null,null,null,null,null,null,null,null,null],\"disease_id\":[\"OMIM:602433\",\"OMIM:620285\",\"OMIM:205100\",\"OMIM:617892\",\"OMIM:602433\",\"OMIM:602433\",\"OMIM:620285\",\"OMIM:205100\",\"OMIM:617892\",\"OMIM:602433\",\"OMIM:620285\",\"OMIM:620285\",\"OMIM:205100\",\"OMIM:617892\",\"OMIM:602433\",\"OMIM:620285\",\"OMIM:205100\",\"OMIM:617892\"],\"ontLvl\":[null,null,null,null,7,5,6,9,12,null,null,null,null,null,null,null,null,null],\"definition\":[null,null,null,null,\"An abnormally pale appearance of the dorsal portion of the gray substance of the spinal cord. This finding can be observed by histological examination.\",null,\"Normal muscle fibers are polygonal-shaped in cross section, are multinucleated, and have minimal amounts of endomysial connective tissue. In contrast, angulated (also known as angular) muscle fibers have long and narrow vertices (corners) with sharp edges and a pointed tip.\",null,\"Partial or complete wasting (loss) of hippocampus tissue that was once present.\",null,null,null,null,null,null,null,null,null],\"hpo_name\":[\"Pallor of dorsal columns of the spinal cord\",\"Angulated muscle fibers\",\"Difficulty in tongue movements\",\"Hippocampal atrophy\",\"Pallor of dorsal columns of the spinal cord\",\"Diffuse axonal swelling\",\"Angulated muscle fibers\",\"Difficulty in tongue movements\",\"Hippocampal atrophy\",\"Pallor of dorsal columns of the spinal cord\",\"Angulated muscle fibers\",\"Angulated muscle fibers\",\"Difficulty in tongue movements\",\"Hippocampal atrophy\",\"Pallor of dorsal columns of the spinal cord\",\"Angulated muscle fibers\",\"Difficulty in tongue movements\",\"Hippocampal atrophy\"],\"hpo_id\":[\"HP:0006825\",\"HP:0034045\",\"HP:0000183\",\"HP:0410170\",\"HP:0006825\",\"HP:0003405\",\"HP:0034045\",\"HP:0000183\",\"HP:0410170\",\"HP:0006825\",\"HP:0034045\",\"HP:0034045\",\"HP:0000183\",\"HP:0410170\",\"HP:0006825\",\"HP:0034045\",\"HP:0000183\",\"HP:0410170\"],\"disease_name\":[\"Amyotrophic lateral sclerosis 4, juvenile\",\"Amyotrophic lateral sclerosis 27, juvenile\",\"Amyotrophic lateral sclerosis 2, juvenile\",\"Amyotrophic lateral sclerosis, susceptibility to, 24\",\"Amyotrophic lateral sclerosis 4, juvenile\",\"Amyotrophic lateral sclerosis 4, juvenile\",\"Amyotrophic lateral sclerosis 27, juvenile\",\"Amyotrophic lateral sclerosis 2, juvenile\",\"Amyotrophic lateral sclerosis, susceptibility to, 24\",\"Amyotrophic lateral sclerosis 4, juvenile\",\"Amyotrophic lateral sclerosis 27, juvenile\",\"Amyotrophic lateral sclerosis 27, juvenile\",\"Amyotrophic lateral sclerosis 2, juvenile\",\"Amyotrophic lateral sclerosis, susceptibility to, 24\",\"Amyotrophic lateral sclerosis 4, juvenile\",\"Amyotrophic lateral sclerosis 27, juvenile\",\"Amyotrophic lateral sclerosis 2, juvenile\",\"Amyotrophic lateral sclerosis, susceptibility to, 24\"],\"shape\":[\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"box\",\"box\",\"box\",\"box\"],\"title\":[\"<b>node<\\/b>= Amyotrophic lateral sclerosis 4, juvenile<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Adult_Fetal_acinar_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:602433<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Pallor of dorsal columns of the spinal cord<br><b>hpo_id<\\/b>= HP:0006825<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 4, juvenile<br><b>shape<\\/b>= database<br><b>name<\\/b>= Amyotrophic lateral sclerosis 4, juvenile<br>\",\"<b>node<\\/b>= Amyotrophic lateral sclerosis 27, juvenile<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0.001<br><b>CellType<\\/b>= Adult_Fetal_fibroblast<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620285<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Angulated muscle fibers<br><b>hpo_id<\\/b>= HP:0034045<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 27, juvenile<br><b>shape<\\/b>= database<br><b>name<\\/b>= Amyotrophic lateral sclerosis 27, juvenile<br>\",\"<b>node<\\/b>= Amyotrophic lateral sclerosis 2, juvenile<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_Proximal_tubule_progenitor<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:205100<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Difficulty in tongue movements<br><b>hpo_id<\\/b>= HP:0000183<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 2, juvenile<br><b>shape<\\/b>= database<br><b>name<\\/b>= Amyotrophic lateral sclerosis 2, juvenile<br>\",\"<b>node<\\/b>= Amyotrophic lateral sclerosis, susceptibility to, 24<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= SLC24A4_PEX5L_positive_cells<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:617892<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Hippocampal atrophy<br><b>hpo_id<\\/b>= HP:0410170<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis, susceptibility to, 24<br><b>shape<\\/b>= database<br><b>name<\\/b>= Amyotrophic lateral sclerosis, susceptibility to, 24<br>\",\"<b>node<\\/b>= Pallor of dorsal columns of the spinal cord<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Adult_Fetal_acinar_cell<br><b>ancestor_name<\\/b>= Abnormality of the nervous system<br><b>disease_id<\\/b>= OMIM:602433<br><b>ontLvl<\\/b>= 7<br><b>definition<\\/b>= An abnormally pale appearance of the dorsal portion of\\nthe gray substance of the spinal cord. This finding can be\\nobserved by histological examination.<br><b>hpo_name<\\/b>= Pallor of dorsal columns of the spinal cord<br><b>hpo_id<\\/b>= HP:0006825<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 4, juvenile<br><b>shape<\\/b>= database<br><b>name<\\/b>= Pallor of dorsal columns of the spinal cord<br>\",\"<b>node<\\/b>= Diffuse axonal swelling<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Adult_Fetal_acinar_cell<br><b>ancestor_name<\\/b>= Abnormality of the nervous system<br><b>disease_id<\\/b>= OMIM:602433<br><b>ontLvl<\\/b>= 5<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Diffuse axonal swelling<br><b>hpo_id<\\/b>= HP:0003405<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 4, juvenile<br><b>shape<\\/b>= database<br><b>name<\\/b>= Diffuse axonal swelling<br>\",\"<b>node<\\/b>= Angulated muscle fibers<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0.001<br><b>CellType<\\/b>= Adult_Fetal_fibroblast<br><b>ancestor_name<\\/b>= Abnormality of the musculoskeletal system<br><b>disease_id<\\/b>= OMIM:620285<br><b>ontLvl<\\/b>= 6<br><b>definition<\\/b>= Normal muscle fibers are polygonal-shaped in cross section,\\nare multinucleated, and have minimal amounts of endomysial\\nconnective tissue. In contrast, angulated (also known\\nas angular) muscle fibers have long and narrow vertices\\n(corners) with sharp edges and a pointed tip.<br><b>hpo_name<\\/b>= Angulated muscle fibers<br><b>hpo_id<\\/b>= HP:0034045<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 27, juvenile<br><b>shape<\\/b>= database<br><b>name<\\/b>= Angulated muscle fibers<br>\",\"<b>node<\\/b>= Difficulty in tongue movements<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_Proximal_tubule_progenitor<br><b>ancestor_name<\\/b>= Abnormality of head or neck<br><b>disease_id<\\/b>= OMIM:205100<br><b>ontLvl<\\/b>= 9<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Difficulty in tongue movements<br><b>hpo_id<\\/b>= HP:0000183<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 2, juvenile<br><b>shape<\\/b>= database<br><b>name<\\/b>= Difficulty in tongue movements<br>\",\"<b>node<\\/b>= Hippocampal atrophy<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= SLC24A4_PEX5L_positive_cells<br><b>ancestor_name<\\/b>= Abnormality of the nervous system<br><b>disease_id<\\/b>= OMIM:617892<br><b>ontLvl<\\/b>= 12<br><b>definition<\\/b>= Partial or complete wasting (loss) of hippocampus tissue\\nthat was once present.<br><b>hpo_name<\\/b>= Hippocampal atrophy<br><b>hpo_id<\\/b>= HP:0410170<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis, susceptibility to, 24<br><b>shape<\\/b>= database<br><b>name<\\/b>= Hippocampal atrophy<br>\",\"<b>node<\\/b>= acinar cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Adult_Fetal_acinar_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:602433<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Pallor of dorsal columns of the spinal cord<br><b>hpo_id<\\/b>= HP:0006825<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 4, juvenile<br><b>shape<\\/b>= circle<br><b>name<\\/b>= acinar cell<br>\",\"<b>node<\\/b>= fibroblast<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.001<br><b>CellType<\\/b>= Adult_Fetal_fibroblast<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620285<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Angulated muscle fibers<br><b>hpo_id<\\/b>= HP:0034045<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 27, juvenile<br><b>shape<\\/b>= circle<br><b>name<\\/b>= fibroblast<br>\",\"<b>node<\\/b>= neuron<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.022<br><b>CellType<\\/b>= Adult_Fetal_Neuron<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620285<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Angulated muscle fibers<br><b>hpo_id<\\/b>= HP:0034045<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 27, juvenile<br><b>shape<\\/b>= circle<br><b>name<\\/b>= neuron<br>\",\"<b>node<\\/b>= epithelial cell of proximal tubule<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_Proximal_tubule_progenitor<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:205100<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Difficulty in tongue movements<br><b>hpo_id<\\/b>= HP:0000183<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 2, juvenile<br><b>shape<\\/b>= circle<br><b>name<\\/b>= epithelial cell of proximal tubule<br>\",\"<b>node<\\/b>= Purkinje cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.002<br><b>CellType<\\/b>= Purkinje_neurons<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:617892<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Hippocampal atrophy<br><b>hpo_id<\\/b>= HP:0410170<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis, susceptibility to, 24<br><b>shape<\\/b>= circle<br><b>name<\\/b>= Purkinje cell<br>\",\"<b>node<\\/b>= SETX<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Adult_Fetal_acinar_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:602433<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Pallor of dorsal columns of the spinal cord<br><b>hpo_id<\\/b>= HP:0006825<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 4, juvenile<br><b>shape<\\/b>= box<br><b>name<\\/b>= SETX<br>\",\"<b>node<\\/b>= SPTLC1<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0.001<br><b>CellType<\\/b>= Adult_Fetal_fibroblast<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620285<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Angulated muscle fibers<br><b>hpo_id<\\/b>= HP:0034045<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 27, juvenile<br><b>shape<\\/b>= box<br><b>name<\\/b>= SPTLC1<br>\",\"<b>node<\\/b>= ALS2<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_Proximal_tubule_progenitor<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:205100<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Difficulty in tongue movements<br><b>hpo_id<\\/b>= HP:0000183<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis 2, juvenile<br><b>shape<\\/b>= box<br><b>name<\\/b>= ALS2<br>\",\"<b>node<\\/b>= NEK1<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= SLC24A4_PEX5L_positive_cells<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:617892<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Hippocampal atrophy<br><b>hpo_id<\\/b>= HP:0410170<br><b>disease_name<\\/b>= Amyotrophic lateral sclerosis, susceptibility to, 24<br><b>shape<\\/b>= box<br><b>name<\\/b>= NEK1<br>\"],\"degree\":[4,4,2,6,2,2,4,2,6,6,3,9,3,3,2,2,1,3],\"value\":[6,6,8,4,8,8,6,8,4,4,7,1,7,7,8,8,9,7],\"color\":[\"#000C7D\",\"#000C7D\",\"#000C7D\",\"#000C7D\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FFF123\",\"#FFF123\",\"#FFF123\",\"#FFF123\"],\"label\":[\"Amyotrophic\\nlateral\\nsclerosis\\n4,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis\\n27,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis\\n2,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis,\\nsusceptibility\\nto, 24\",\"Pallor\\nof dorsal\\ncolumns of\\nthe spinal\\ncord\",\"Diffuse\\naxonal\\nswelling\",\"Angulated\\nmuscle\\nfibers\",\"Difficulty\\nin tongue\\nmovements\",\"Hippocampal\\natrophy\",\"acinar\\ncell\",\"fibroblast\",\"neuron\",\"epithelial\\ncell of\\nproximal\\ntubule\",\"Purkinje\\ncell\",\"SETX\",\"SPTLC1\",\"ALS2\",\"NEK1\"],\"x\":[-0.7391304347826086,-0.1304347826086957,1,0.5652173913043479,-1,-0.8260869565217391,-0.1304347826086957,0.9130434782608696,0.5652173913043479,-0.7391304347826086,-0.2173913043478261,0.3043478260869565,1,0.7391304347826086,-0.7391304347826086,-0.2173913043478261,1,0.3043478260869565],\"y\":[-1,-1,-1,-1,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,1,1,1,1]},\"edges\":{\"from\":[\"Amyotrophic\\nlateral\\nsclerosis\\n4,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis\\n4,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis\\n27,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis\\n27,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis\\n2,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis,\\nsusceptibility\\nto, 24\",\"Amyotrophic\\nlateral\\nsclerosis,\\nsusceptibility\\nto, 24\",\"Amyotrophic\\nlateral\\nsclerosis,\\nsusceptibility\\nto, 24\",\"Pallor\\nof dorsal\\ncolumns of\\nthe spinal\\ncord\",\"Diffuse\\naxonal\\nswelling\",\"Angulated\\nmuscle\\nfibers\",\"Angulated\\nmuscle\\nfibers\",\"Difficulty\\nin tongue\\nmovements\",\"Hippocampal\\natrophy\",\"Hippocampal\\natrophy\",\"Hippocampal\\natrophy\",\"acinar\\ncell\",\"acinar\\ncell\",\"fibroblast\",\"neuron\",\"epithelial\\ncell of\\nproximal\\ntubule\",\"neuron\",\"Purkinje\\ncell\",\"neuron\",\"Amyotrophic\\nlateral\\nsclerosis\\n4,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis\\n4,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis\\n27,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis\\n27,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis\\n2,\\njuvenile\",\"Amyotrophic\\nlateral\\nsclerosis,\\nsusceptibility\\nto, 24\",\"Amyotrophic\\nlateral\\nsclerosis,\\nsusceptibility\\nto, 24\",\"Amyotrophic\\nlateral\\nsclerosis,\\nsusceptibility\\nto, 24\"],\"to\":[\"Pallor\\nof dorsal\\ncolumns of\\nthe spinal\\ncord\",\"Diffuse\\naxonal\\nswelling\",\"Angulated\\nmuscle\\nfibers\",\"Angulated\\nmuscle\\nfibers\",\"Difficulty\\nin tongue\\nmovements\",\"Hippocampal\\natrophy\",\"Hippocampal\\natrophy\",\"Hippocampal\\natrophy\",\"acinar\\ncell\",\"acinar\\ncell\",\"fibroblast\",\"neuron\",\"epithelial\\ncell of\\nproximal\\ntubule\",\"neuron\",\"Purkinje\\ncell\",\"neuron\",\"SETX\",\"SETX\",\"SPTLC1\",\"SPTLC1\",\"ALS2\",\"NEK1\",\"NEK1\",\"NEK1\",\"acinar\\ncell\",\"acinar\\ncell\",\"fibroblast\",\"neuron\",\"epithelial\\ncell of\\nproximal\\ntubule\",\"neuron\",\"Purkinje\\ncell\",\"neuron\"],\"color\":[1.173300249768126,1.113282970095135,0.6965740769392408,0.6965740769392408,0.8240466560233269,0.8278594124714753,0.8278594124714753,0.8278594124714753,1.173300249768126,1.113282970095135,0.7571913639764551,0.6359567899020265,0.8240466560233269,0.8898069278375089,0.7039643817394078,0.8898069278375089,1.14329160993163,1.14329160993163,0.7571913639764551,0.6359567899020265,0.8240466560233269,0.8898069278375089,0.7039643817394078,0.8898069278375089,1.14329160993163,1.14329160993163,0.7571913639764551,0.6359567899020265,0.8240466560233269,0.8898069278375089,0.7039643817394078,0.8898069278375089],\"width\":[1.173300249768126,1.113282970095135,0.7571913639764551,0.6359567899020265,0.8240466560233269,1.098418434935805,0.7039643817394078,0.6811954207392134,1.173300249768126,1.113282970095135,0.7571913639764551,0.6359567899020265,0.8240466560233269,1.098418434935805,0.7039643817394078,0.6811954207392134,1.173300249768126,1.113282970095135,0.7571913639764551,0.6359567899020265,0.8240466560233269,1.098418434935805,0.7039643817394078,0.6811954207392134,1.173300249768126,1.113282970095135,0.7571913639764551,0.6359567899020265,0.8240466560233269,1.098418434935805,0.7039643817394078,0.6811954207392134]},\"nodesToDataframe\":true,\"edgesToDataframe\":true,\"options\":{\"width\":\"100%\",\"height\":\"100%\",\"nodes\":{\"shape\":\"dot\",\"physics\":false,\"borderWidth\":3,\"borderWidthSelected\":6,\"color\":{\"hover\":{\"background\":\"rgba(0,0,0,.5)\"},\"highlight\":{\"background\":\"#00FFFFCF\",\"border\":\"#00FFFFCF\"}},\"opacity\":0.75,\"font\":{\"color\":\"#F0FFFF\",\"strokeWidth\":2,\"strokeColor\":\"rgba(0,0,0,1)\"},\"shadow\":{\"enabled\":true,\"size\":10}},\"manipulation\":{\"enabled\":false},\"edges\":{\"arrows\":\"from\",\"color\":{\"opacity\":0.5},\"smooth\":{\"enabled\":true,\"type\":\"cubicBezier\",\"roundness\":0.5},\"shadow\":{\"enabled\":false}},\"physics\":{\"solver\":\"forceAtlas2Based\",\"enabled\":false,\"forceAtlas2Based\":{\"avoidOverlap\":0.5,\"gravitationalConstant\":-50}},\"interaction\":{\"hover\":true,\"zoomSpeed\":1}},\"groups\":null,\"width\":\"100%\",\"height\":\"60vh\",\"idselection\":{\"enabled\":false,\"style\":\"width: 150px; height: 26px\",\"useLabels\":true,\"main\":\"Select by id\"},\"byselection\":{\"enabled\":false,\"style\":\"width: 150px; height: 26px\",\"multiple\":false,\"hideColor\":\"rgba(200,200,200,0.5)\",\"highlight\":false,\"variable\":\"name\",\"main\":\"Select by name\"},\"main\":{\"text\":\"amyotrophic lateral sclerosis\",\"style\":\"font-family:Georgia, Times New Roman, Times, serif;font-weight:bold;font-size:20px;text-align:center;\"},\"submain\":null,\"footer\":null,\"background\":\"transparent\",\"igraphlayout\":{\"type\":\"full\"},\"tooltipStay\":300,\"tooltipStyle\":\"position: fixed;visibility:hidden;padding: 5px;white-space: nowrap;font-family: verdana;font-size:14px;font-color:#000000;background-color: #f5f4ed;-moz-border-radius: 3px;-webkit-border-radius: 3px;border-radius: 3px;border: 1px solid #808074;box-shadow: 3px 3px 10px rgba(0, 0, 0, 0.2);\",\"highlight\":{\"enabled\":true,\"hoverNearest\":false,\"degree\":1,\"algorithm\":\"all\",\"hideColor\":\"rgba(200,200,200,0.5)\",\"labelOnly\":true},\"collapse\":{\"enabled\":false,\"fit\":false,\"resetHighlight\":true,\"clusterOptions\":null,\"keepCoord\":true,\"labelSuffix\":\"(cluster)\"},\"events\":{\"doubleClick\":\"function(){ this.fit()}\"}},\"evals\":[\"events.doubleClick\"],\"jsHooks\":[]}</script>\n```\n\n\nAlzheimer disease\n\n```{.r .cell-code .hidden}\n#| label: fig-therapy-examples-supp\n#| layout: [[1,1], [1,1]]\n#| fig-cap: Example cell type-specific gene therapy targets for several severe phenotypes and their associated diseases. Each disease (blue cylinders) is connected to its phenotype (purple cylinders) based on well-established clinical observations recorded within the HPO [@Gargano2024-fc].Phenotypes are connected to cell types (red circles) via association testing between weighted gene sets ($FDR_{p,c}<0.05$). Each cell type is connected to the prioritised gene targets (yellow boxes) based on the driver gene analysis.The thickness of the edges connecting the nodes represent the (mean) fold-change from the bootstrapped enrichment tests. Nodes were spatially arranged using the Sugiyama algorithm [@Sugiyama1981-ev].\n#| fig-subcap:\n#| - 'Respiratory failure'\n#| - 'Alzheimer disease'\n#| - 'Parkinson disease'\n\nvn_therapy_eg3$plot\n```\n\n```{=html}\n<div id=\"htmlwidget-469f2da06c6d69abe390\" style=\"width:100%;height:60vh;\" class=\"visNetwork html-widget\"></div>\n<script type=\"application/json\" data-for=\"htmlwidget-469f2da06c6d69abe390\">{\"x\":{\"nodes\":{\"id\":[\"Neurodegeneration,\\nchildhood-onset,\\nwith\\nmultisystem\\ninvolvement\\ndue to\\nmitochondrial\\ndysfunction\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration\\nwith\\ndevelopmental\\ndelay,\\nearly\\nrespiratory\\nfailure,\\nmyoclonic\\nseizures,\\nand brain\\nabnormalities\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n1\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n4\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n2B\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\",\"Metabolic\\nencephalomyopathic\\ncrises,\\nrecurrent,\\nwith\\nrhabdomyolysis,\\ncardiac\\narrhythmias,\\nand\\nneurodegeneration\",\"Fibrosis,\\nneurodegeneration,\\nand\\ncerebral\\nangiomatosis\",\"Neurodegeneration,\\nchildhood-onset,\\nwith\\ncerebellar\\natrophy\",\"Opto-chiasmatic\\natrophy\",\"Cavitation\\nof the\\nbasal\\nganglia\",\"Dysgyria\",\"Cerebral\\ndegeneration\",\"Eye of\\nthe tiger\\nanomaly\\nof globus\\npallidus\",\"Neurofibrillary\\ntangles\",\"Increased\\nskull\\nossification\",\"Micrographia\",\"Anarthria\",\"Poor\\ncoordination\",\"Unconjugated\\nhyperbilirubinemia\",\"Laryngeal\\ndystonia\",\"Elevated\\nurine\\nacetoacetic\\nacid level\",\"Hepatocellular\\nnecrosis\",\"Upgaze\\npalsy\",\"Decreased\\ncirculating\\nferritin\\nconcentration\",\"Sclerotic\\nvertebral\\nbody\",\"basal cell\",\"alternatively\\nactivated\\nmacrophage\",\"macrophage\",\"embryonic\\nstem cell\",\"endocrine\\ncell\",\"primordial\\ngerm cell\",\"mast cell\",\"erythroblast\",\"Sertoli\\ncell\",\"T cell\",\"monocyte\",\"microglial\\ncell\",\"myeloid\\ncell\",\"renal\\nintercalated\\ncell\",\"LETM1\",\"FTL\",\"MED11\",\"PANK2\",\"C19orf12\",\"PLA2G6\",\"CSF1R\",\"TANGO2\",\"NHLRC2\",\"AGTPBP1\"],\"node\":[\"Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction\",\"Neurodegeneration with brain iron accumulation 3\",\"Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities\",\"Neurodegeneration with brain iron accumulation 1\",\"Neurodegeneration with brain iron accumulation 4\",\"Neurodegeneration with brain iron accumulation 2B\",\"Brain abnormalities, neurodegeneration, and dysosteosclerosis\",\"Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration\",\"Fibrosis, neurodegeneration, and cerebral angiomatosis\",\"Neurodegeneration, childhood-onset, with cerebellar atrophy\",\"Opto-chiasmatic atrophy\",\"Cavitation of the basal ganglia\",\"Dysgyria\",\"Cerebral degeneration\",\"Eye of the tiger anomaly of globus pallidus\",\"Neurofibrillary tangles\",\"Increased skull ossification\",\"Micrographia\",\"Anarthria\",\"Poor coordination\",\"Unconjugated hyperbilirubinemia\",\"Laryngeal dystonia\",\"Elevated urine acetoacetic acid level\",\"Hepatocellular necrosis\",\"Upgaze palsy\",\"Decreased circulating ferritin concentration\",\"Sclerotic vertebral body\",\"basal cell\",\"alternatively activated macrophage\",\"macrophage\",\"embryonic stem cell\",\"endocrine cell\",\"primordial germ cell\",\"mast cell\",\"erythroblast\",\"Sertoli cell\",\"T cell\",\"monocyte\",\"microglial cell\",\"myeloid cell\",\"renal intercalated cell\",\"LETM1\",\"FTL\",\"MED11\",\"PANK2\",\"C19orf12\",\"PLA2G6\",\"CSF1R\",\"TANGO2\",\"NHLRC2\",\"AGTPBP1\"],\"node_type\":[\"disease_name\",\"disease_name\",\"disease_name\",\"disease_name\",\"disease_name\",\"disease_name\",\"disease_name\",\"disease_name\",\"disease_name\",\"disease_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"gene_symbol\",\"gene_symbol\",\"gene_symbol\",\"gene_symbol\",\"gene_symbol\",\"gene_symbol\",\"gene_symbol\",\"gene_symbol\",\"gene_symbol\",\"gene_symbol\"],\"q\":[0.0339363457975544,2.70383853055648e-08,0.00982812955879336,0.0327657536942714,0.0214459995568952,0.0178982337631289,0.0151288999922698,0.00362688792086094,3.79800527690217e-63,0.0175319662786263,0.0339363457975544,2.70383853055648e-08,0.00982812955879336,0.0327657536942714,0.0214459995568952,0.0178982337631289,0.0151288999922698,0.0154451653816604,0.000321792942194677,0.00362688792086094,3.79800527690217e-63,6.06771216640436e-05,1.79327959124976e-10,1.44398268325058e-06,0.0175319662786263,5.51723855718294e-06,1.28201399118736e-10,0.0339363457975544,2.70383853055648e-08,0.00517669413483996,0.00982812955879336,0.0327657536942714,0.0214459995568952,0.00362688792086094,3.79800527690217e-63,1.79327959124976e-10,1.44398268325058e-06,0.0175319662786263,1.28201399118736e-10,0.00072362500836516,0.0206848856495586,0.0339363457975544,2.70383853055648e-08,0.00982812955879336,0.0327657536942714,0.0214459995568952,0.0178982337631289,0.0151288999922698,0.00362688792086094,3.79800527690217e-63,0.0175319662786263],\"CellType\":[\"Fetus_Basal_cell\",\"Fetus_M2_Macrophage\",\"Adult_hESC\",\"Fetus_Gastric_endocrine_cell\",\"Adult_Primordial_germ_cell\",\"Fetus_M2_Macrophage\",\"Fetus_Macrophage\",\"Fetus_Mast_cell\",\"Erythroblasts\",\"Fetus_Monocyte\",\"Fetus_Basal_cell\",\"Fetus_M2_Macrophage\",\"Adult_hESC\",\"Fetus_Gastric_endocrine_cell\",\"Adult_Primordial_germ_cell\",\"Fetus_M2_Macrophage\",\"Fetus_Macrophage\",\"Fetus_M2_Macrophage\",\"Fetus_M2_Macrophage\",\"Fetus_Mast_cell\",\"Erythroblasts\",\"Fetus_M2_Macrophage\",\"Fetus_Immature_sertoli_cell_(Pre_Sertoli_cell)\",\"HESC_Proliferating_T_cell\",\"Fetus_Monocyte\",\"Fetus_M2_Macrophage\",\"Microglia\",\"Fetus_Basal_cell\",\"Fetus_M2_Macrophage\",\"Fetus_Macrophage\",\"Adult_hESC\",\"Fetus_Gastric_endocrine_cell\",\"Adult_Primordial_germ_cell\",\"Fetus_Mast_cell\",\"Erythroblasts\",\"Fetus_Immature_sertoli_cell_(Pre_Sertoli_cell)\",\"HESC_Proliferating_T_cell\",\"Fetus_Monocyte\",\"Microglia\",\"Myeloid_cells\",\"Fetus_Kidney_intercalated_cell\",\"Fetus_Basal_cell\",\"Fetus_M2_Macrophage\",\"Adult_hESC\",\"Fetus_Gastric_endocrine_cell\",\"Adult_Primordial_germ_cell\",\"Fetus_M2_Macrophage\",\"Fetus_Macrophage\",\"Fetus_Mast_cell\",\"Erythroblasts\",\"Fetus_Monocyte\"],\"ancestor_name\":[null,null,null,null,null,null,null,null,null,null,\"Abnormality of the eye\",\"Abnormality of the nervous system\",\"Abnormality of the nervous system\",\"Abnormality of the nervous system\",\"Abnormality of the nervous system\",\"Abnormality of the nervous system\",\"Abnormality of head or neck\",\"Abnormality of the nervous system\",\"Abnormality of the nervous system\",\"Abnormality of the nervous system\",\"Abnormality of metabolism/homeostasis\",\"Abnormality of the nervous system\",\"Abnormality of the genitourinary system\",\"Abnormality of the digestive system\",\"Abnormality of the eye\",\"Abnormality of metabolism/homeostasis\",\"Abnormality of the musculoskeletal system\",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null],\"disease_id\":[\"OMIM:620089\",\"OMIM:606159\",\"OMIM:620327\",\"OMIM:234200\",\"OMIM:614298\",\"OMIM:610217\",\"OMIM:618476\",\"OMIM:616878\",\"OMIM:618278\",\"OMIM:618276\",\"OMIM:620089\",\"OMIM:606159\",\"OMIM:620327\",\"OMIM:234200\",\"OMIM:234200\",\"OMIM:610217\",\"OMIM:618476\",\"OMIM:606159\",\"OMIM:606159\",\"OMIM:616878\",\"OMIM:618278\",\"OMIM:606159\",\"OMIM:620089\",\"OMIM:618278\",\"OMIM:618276\",\"OMIM:606159\",\"OMIM:618476\",\"OMIM:620089\",\"OMIM:606159\",\"OMIM:606159\",\"OMIM:620327\",\"OMIM:234200\",\"OMIM:234200\",\"OMIM:616878\",\"OMIM:618278\",\"OMIM:620089\",\"OMIM:618278\",\"OMIM:618276\",\"OMIM:618476\",\"OMIM:618476\",\"OMIM:618476\",\"OMIM:620089\",\"OMIM:606159\",\"OMIM:620327\",\"OMIM:234200\",\"OMIM:614298\",\"OMIM:610217\",\"OMIM:618476\",\"OMIM:616878\",\"OMIM:618278\",\"OMIM:618276\"],\"ontLvl\":[null,null,null,null,null,null,null,null,null,null,8,10,10,9,11,9,9,5,7,7,9,7,8,7,8,6,8,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null],\"definition\":[null,null,null,null,null,null,null,null,null,null,\"Wasting (atrophy) of the optic chiasm.\",\"The formation of small cavities in the tissue of the basal ganglia.\",\"An abnormal gyral pattern characterized by abnormalities of sulcal depth or orientation.\",null,\"The presence, on T2-weighted magnetic resonance imaging, of markedly low signal intensity of the globus pallidus that surrounds a central region of high signal intensity in the anteromedial globus pallidus, producing an eye-of-the-tiger appearance. The sign is thought to represent iron accumulation in the globus pallidus.\",\"Pathological protein aggregates formed by hyperphosphorylation of a microtubule-associated protein known as tau, causing it to aggregate in an insoluble form.\",\"An increase in the magnitude or amount of ossification of the skull.\",\"Abnormally small-sized handwriting is formally defined as an impairment of fine motor skills, which mainly manifests as a progressive or stable reduction in amplitude during a writing task.\",\"A defect in the motor ability that enables speech.\",null,\"An increased amount of unconjugated (indirect) bilurubin in the blood.\",\"A form of focal dystonia that affects the vocal cords, associated with involuntary contractions of the vocal cords causing interruptions of speech and affecting the voice quality and often leading to patterned, repeated breaks in speech.\",\"Elevated amount of acetoacetic acid in the urine.\",null,\"A limitation of the ability to direct one's gaze above the horizontal meridian.\",\"Abnormally reduced concentration of ferritin, a ubiquitous intracellular protein that stores iron, in the blood.\",\"Increase in bone density of the vertebral body.\",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null],\"hpo_name\":[\"Opto-chiasmatic atrophy\",\"Cavitation of the basal ganglia\",\"Dysgyria\",\"Cerebral degeneration\",\"Eye of the tiger anomaly of globus pallidus\",\"Neurofibrillary tangles\",\"Increased skull ossification\",\"Poor coordination\",\"Unconjugated hyperbilirubinemia\",\"Upgaze palsy\",\"Opto-chiasmatic atrophy\",\"Cavitation of the basal ganglia\",\"Dysgyria\",\"Cerebral degeneration\",\"Eye of the tiger anomaly of globus pallidus\",\"Neurofibrillary tangles\",\"Increased skull ossification\",\"Micrographia\",\"Anarthria\",\"Poor coordination\",\"Unconjugated hyperbilirubinemia\",\"Laryngeal dystonia\",\"Elevated urine acetoacetic acid level\",\"Hepatocellular necrosis\",\"Upgaze palsy\",\"Decreased circulating ferritin concentration\",\"Sclerotic vertebral body\",\"Opto-chiasmatic atrophy\",\"Cavitation of the basal ganglia\",\"Cavitation of the basal ganglia\",\"Dysgyria\",\"Cerebral degeneration\",\"Eye of the tiger anomaly of globus pallidus\",\"Poor coordination\",\"Unconjugated hyperbilirubinemia\",\"Elevated urine acetoacetic acid level\",\"Hepatocellular necrosis\",\"Upgaze palsy\",\"Sclerotic vertebral body\",\"Sclerotic vertebral body\",\"Sclerotic vertebral body\",\"Opto-chiasmatic atrophy\",\"Cavitation of the basal ganglia\",\"Dysgyria\",\"Cerebral degeneration\",\"Eye of the tiger anomaly of globus pallidus\",\"Neurofibrillary tangles\",\"Increased skull ossification\",\"Poor coordination\",\"Unconjugated hyperbilirubinemia\",\"Upgaze palsy\"],\"hpo_id\":[\"HP:0034008\",\"HP:0007007\",\"HP:0032398\",\"HP:0007313\",\"HP:0002454\",\"HP:0002185\",\"HP:0004330\",\"HP:0002370\",\"HP:0008282\",\"HP:0025331\",\"HP:0034008\",\"HP:0007007\",\"HP:0032398\",\"HP:0007313\",\"HP:0002454\",\"HP:0002185\",\"HP:0004330\",\"HP:0031908\",\"HP:0002425\",\"HP:0002370\",\"HP:0008282\",\"HP:0012049\",\"HP:0033407\",\"HP:0001404\",\"HP:0025331\",\"HP:0012343\",\"HP:0100861\",\"HP:0034008\",\"HP:0007007\",\"HP:0007007\",\"HP:0032398\",\"HP:0007313\",\"HP:0002454\",\"HP:0002370\",\"HP:0008282\",\"HP:0033407\",\"HP:0001404\",\"HP:0025331\",\"HP:0100861\",\"HP:0100861\",\"HP:0100861\",\"HP:0034008\",\"HP:0007007\",\"HP:0032398\",\"HP:0007313\",\"HP:0002454\",\"HP:0002185\",\"HP:0004330\",\"HP:0002370\",\"HP:0008282\",\"HP:0025331\"],\"disease_name\":[\"Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction\",\"Neurodegeneration with brain iron accumulation 3\",\"Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities\",\"Neurodegeneration with brain iron accumulation 1\",\"Neurodegeneration with brain iron accumulation 4\",\"Neurodegeneration with brain iron accumulation 2B\",\"Brain abnormalities, neurodegeneration, and dysosteosclerosis\",\"Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration\",\"Fibrosis, neurodegeneration, and cerebral angiomatosis\",\"Neurodegeneration, childhood-onset, with cerebellar atrophy\",\"Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction\",\"Neurodegeneration with brain iron accumulation 3\",\"Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities\",\"Neurodegeneration with brain iron accumulation 1\",\"Neurodegeneration with brain iron accumulation 1\",\"Neurodegeneration with brain iron accumulation 2B\",\"Brain abnormalities, neurodegeneration, and dysosteosclerosis\",\"Neurodegeneration with brain iron accumulation 3\",\"Neurodegeneration with brain iron accumulation 3\",\"Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration\",\"Fibrosis, neurodegeneration, and cerebral angiomatosis\",\"Neurodegeneration with brain iron accumulation 3\",\"Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction\",\"Fibrosis, neurodegeneration, and cerebral angiomatosis\",\"Neurodegeneration, childhood-onset, with cerebellar atrophy\",\"Neurodegeneration with brain iron accumulation 3\",\"Brain abnormalities, neurodegeneration, and dysosteosclerosis\",\"Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction\",\"Neurodegeneration with brain iron accumulation 3\",\"Neurodegeneration with brain iron accumulation 3\",\"Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities\",\"Neurodegeneration with brain iron accumulation 1\",\"Neurodegeneration with brain iron accumulation 1\",\"Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration\",\"Fibrosis, neurodegeneration, and cerebral angiomatosis\",\"Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction\",\"Fibrosis, neurodegeneration, and cerebral angiomatosis\",\"Neurodegeneration, childhood-onset, with cerebellar atrophy\",\"Brain abnormalities, neurodegeneration, and dysosteosclerosis\",\"Brain abnormalities, neurodegeneration, and dysosteosclerosis\",\"Brain abnormalities, neurodegeneration, and dysosteosclerosis\",\"Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction\",\"Neurodegeneration with brain iron accumulation 3\",\"Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities\",\"Neurodegeneration with brain iron accumulation 1\",\"Neurodegeneration with brain iron accumulation 4\",\"Neurodegeneration with brain iron accumulation 2B\",\"Brain abnormalities, neurodegeneration, and dysosteosclerosis\",\"Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration\",\"Fibrosis, neurodegeneration, and cerebral angiomatosis\",\"Neurodegeneration, childhood-onset, with cerebellar atrophy\"],\"shape\":[\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"database\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"box\",\"box\",\"box\",\"box\",\"box\",\"box\",\"box\",\"box\",\"box\",\"box\"],\"title\":[\"<b>node<\\/b>= Neurodegeneration, childhood-onset, with multisystem\\ninvolvement due to mitochondrial dysfunction<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0.034<br><b>CellType<\\/b>= Fetus_Basal_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620089<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Opto-chiasmatic atrophy<br><b>hpo_id<\\/b>= HP:0034008<br><b>disease_name<\\/b>= Neurodegeneration, childhood-onset, with multisystem\\ninvolvement due to mitochondrial dysfunction<br><b>shape<\\/b>= database<br><b>name<\\/b>= Neurodegeneration, childhood-onset, with multisystem\\ninvolvement due to mitochondrial dysfunction<br>\",\"<b>node<\\/b>= Neurodegeneration with brain iron accumulation 3<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_M2_Macrophage<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:606159<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Cavitation of the basal ganglia<br><b>hpo_id<\\/b>= HP:0007007<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 3<br><b>shape<\\/b>= database<br><b>name<\\/b>= Neurodegeneration with brain iron accumulation 3<br>\",\"<b>node<\\/b>= Neurodegeneration with developmental delay, early\\nrespiratory failure, myoclonic seizures, and brain\\nabnormalities<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0.01<br><b>CellType<\\/b>= Adult_hESC<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620327<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Dysgyria<br><b>hpo_id<\\/b>= HP:0032398<br><b>disease_name<\\/b>= Neurodegeneration with developmental delay, early\\nrespiratory failure, myoclonic seizures, and brain\\nabnormalities<br><b>shape<\\/b>= database<br><b>name<\\/b>= Neurodegeneration with developmental delay, early\\nrespiratory failure, myoclonic seizures, and brain\\nabnormalities<br>\",\"<b>node<\\/b>= Neurodegeneration with brain iron accumulation 1<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0.033<br><b>CellType<\\/b>= Fetus_Gastric_endocrine_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:234200<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Cerebral degeneration<br><b>hpo_id<\\/b>= HP:0007313<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 1<br><b>shape<\\/b>= database<br><b>name<\\/b>= Neurodegeneration with brain iron accumulation 1<br>\",\"<b>node<\\/b>= Neurodegeneration with brain iron accumulation 4<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0.021<br><b>CellType<\\/b>= Adult_Primordial_germ_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:614298<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Eye of the tiger anomaly of globus pallidus<br><b>hpo_id<\\/b>= HP:0002454<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 4<br><b>shape<\\/b>= database<br><b>name<\\/b>= Neurodegeneration with brain iron accumulation 4<br>\",\"<b>node<\\/b>= Neurodegeneration with brain iron accumulation 2B<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0.018<br><b>CellType<\\/b>= Fetus_M2_Macrophage<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:610217<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Neurofibrillary tangles<br><b>hpo_id<\\/b>= HP:0002185<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 2B<br><b>shape<\\/b>= database<br><b>name<\\/b>= Neurodegeneration with brain iron accumulation 2B<br>\",\"<b>node<\\/b>= Brain abnormalities, neurodegeneration, and\\ndysosteosclerosis<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0.015<br><b>CellType<\\/b>= Fetus_Macrophage<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:618476<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Increased skull ossification<br><b>hpo_id<\\/b>= HP:0004330<br><b>disease_name<\\/b>= Brain abnormalities, neurodegeneration, and\\ndysosteosclerosis<br><b>shape<\\/b>= database<br><b>name<\\/b>= Brain abnormalities, neurodegeneration, and\\ndysosteosclerosis<br>\",\"<b>node<\\/b>= Metabolic encephalomyopathic crises, recurrent, with\\nrhabdomyolysis, cardiac arrhythmias, and neurodegeneration<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0.004<br><b>CellType<\\/b>= Fetus_Mast_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:616878<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Poor coordination<br><b>hpo_id<\\/b>= HP:0002370<br><b>disease_name<\\/b>= Metabolic encephalomyopathic crises, recurrent, with\\nrhabdomyolysis, cardiac arrhythmias, and neurodegeneration<br><b>shape<\\/b>= database<br><b>name<\\/b>= Metabolic encephalomyopathic crises, recurrent, with\\nrhabdomyolysis, cardiac arrhythmias, and neurodegeneration<br>\",\"<b>node<\\/b>= Fibrosis, neurodegeneration, and cerebral angiomatosis<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Erythroblasts<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:618278<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Unconjugated hyperbilirubinemia<br><b>hpo_id<\\/b>= HP:0008282<br><b>disease_name<\\/b>= Fibrosis, neurodegeneration, and cerebral angiomatosis<br><b>shape<\\/b>= database<br><b>name<\\/b>= Fibrosis, neurodegeneration, and cerebral angiomatosis<br>\",\"<b>node<\\/b>= Neurodegeneration, childhood-onset, with cerebellar atrophy<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0.018<br><b>CellType<\\/b>= Fetus_Monocyte<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:618276<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Upgaze palsy<br><b>hpo_id<\\/b>= HP:0025331<br><b>disease_name<\\/b>= Neurodegeneration, childhood-onset, with cerebellar atrophy<br><b>shape<\\/b>= database<br><b>name<\\/b>= Neurodegeneration, childhood-onset, with cerebellar atrophy<br>\",\"<b>node<\\/b>= Opto-chiasmatic atrophy<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0.034<br><b>CellType<\\/b>= Fetus_Basal_cell<br><b>ancestor_name<\\/b>= Abnormality of the eye<br><b>disease_id<\\/b>= OMIM:620089<br><b>ontLvl<\\/b>= 8<br><b>definition<\\/b>= Wasting (atrophy) of the optic chiasm.<br><b>hpo_name<\\/b>= Opto-chiasmatic atrophy<br><b>hpo_id<\\/b>= HP:0034008<br><b>disease_name<\\/b>= Neurodegeneration, childhood-onset, with multisystem\\ninvolvement due to mitochondrial dysfunction<br><b>shape<\\/b>= database<br><b>name<\\/b>= Opto-chiasmatic atrophy<br>\",\"<b>node<\\/b>= Cavitation of the basal ganglia<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_M2_Macrophage<br><b>ancestor_name<\\/b>= Abnormality of the nervous system<br><b>disease_id<\\/b>= OMIM:606159<br><b>ontLvl<\\/b>= 10<br><b>definition<\\/b>= The formation of small cavities in the tissue of the basal\\nganglia.<br><b>hpo_name<\\/b>= Cavitation of the basal ganglia<br><b>hpo_id<\\/b>= HP:0007007<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 3<br><b>shape<\\/b>= database<br><b>name<\\/b>= Cavitation of the basal ganglia<br>\",\"<b>node<\\/b>= Dysgyria<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0.01<br><b>CellType<\\/b>= Adult_hESC<br><b>ancestor_name<\\/b>= Abnormality of the nervous system<br><b>disease_id<\\/b>= OMIM:620327<br><b>ontLvl<\\/b>= 10<br><b>definition<\\/b>= An abnormal gyral pattern characterized by abnormalities of\\nsulcal depth or orientation.<br><b>hpo_name<\\/b>= Dysgyria<br><b>hpo_id<\\/b>= HP:0032398<br><b>disease_name<\\/b>= Neurodegeneration with developmental delay, early\\nrespiratory failure, myoclonic seizures, and brain\\nabnormalities<br><b>shape<\\/b>= database<br><b>name<\\/b>= Dysgyria<br>\",\"<b>node<\\/b>= Cerebral degeneration<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0.033<br><b>CellType<\\/b>= Fetus_Gastric_endocrine_cell<br><b>ancestor_name<\\/b>= Abnormality of the nervous system<br><b>disease_id<\\/b>= OMIM:234200<br><b>ontLvl<\\/b>= 9<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Cerebral degeneration<br><b>hpo_id<\\/b>= HP:0007313<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 1<br><b>shape<\\/b>= database<br><b>name<\\/b>= Cerebral degeneration<br>\",\"<b>node<\\/b>= Eye of the tiger anomaly of globus pallidus<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0.021<br><b>CellType<\\/b>= Adult_Primordial_germ_cell<br><b>ancestor_name<\\/b>= Abnormality of the nervous system<br><b>disease_id<\\/b>= OMIM:234200<br><b>ontLvl<\\/b>= 11<br><b>definition<\\/b>= The presence, on T2-weighted magnetic resonance imaging, of\\nmarkedly low signal intensity of the globus pallidus that\\nsurrounds a central region of high signal intensity in the\\nanteromedial globus pallidus, producing an eye-of-the-tiger\\nappearance. The sign is thought to represent iron\\naccumulation in the globus pallidus.<br><b>hpo_name<\\/b>= Eye of the tiger anomaly of globus pallidus<br><b>hpo_id<\\/b>= HP:0002454<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 1<br><b>shape<\\/b>= database<br><b>name<\\/b>= Eye of the tiger anomaly of globus pallidus<br>\",\"<b>node<\\/b>= Neurofibrillary tangles<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0.018<br><b>CellType<\\/b>= Fetus_M2_Macrophage<br><b>ancestor_name<\\/b>= Abnormality of the nervous system<br><b>disease_id<\\/b>= OMIM:610217<br><b>ontLvl<\\/b>= 9<br><b>definition<\\/b>= Pathological protein aggregates formed by\\nhyperphosphorylation of a microtubule-associated protein\\nknown as tau, causing it to aggregate in an insoluble form.<br><b>hpo_name<\\/b>= Neurofibrillary tangles<br><b>hpo_id<\\/b>= HP:0002185<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 2B<br><b>shape<\\/b>= database<br><b>name<\\/b>= Neurofibrillary tangles<br>\",\"<b>node<\\/b>= Increased skull ossification<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0.015<br><b>CellType<\\/b>= Fetus_Macrophage<br><b>ancestor_name<\\/b>= Abnormality of head or neck<br><b>disease_id<\\/b>= OMIM:618476<br><b>ontLvl<\\/b>= 9<br><b>definition<\\/b>= An increase in the magnitude or amount of ossification of\\nthe skull.<br><b>hpo_name<\\/b>= Increased skull ossification<br><b>hpo_id<\\/b>= HP:0004330<br><b>disease_name<\\/b>= Brain abnormalities, neurodegeneration, and\\ndysosteosclerosis<br><b>shape<\\/b>= database<br><b>name<\\/b>= Increased skull ossification<br>\",\"<b>node<\\/b>= Micrographia<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0.015<br><b>CellType<\\/b>= Fetus_M2_Macrophage<br><b>ancestor_name<\\/b>= Abnormality of the nervous system<br><b>disease_id<\\/b>= OMIM:606159<br><b>ontLvl<\\/b>= 5<br><b>definition<\\/b>= Abnormally small-sized handwriting is formally defined as\\nan impairment of fine motor skills, which mainly manifests\\nas a progressive or stable reduction in amplitude during a\\nwriting task.<br><b>hpo_name<\\/b>= Micrographia<br><b>hpo_id<\\/b>= HP:0031908<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 3<br><b>shape<\\/b>= database<br><b>name<\\/b>= Micrographia<br>\",\"<b>node<\\/b>= Anarthria<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_M2_Macrophage<br><b>ancestor_name<\\/b>= Abnormality of the nervous system<br><b>disease_id<\\/b>= OMIM:606159<br><b>ontLvl<\\/b>= 7<br><b>definition<\\/b>= A defect in the motor ability that enables speech.<br><b>hpo_name<\\/b>= Anarthria<br><b>hpo_id<\\/b>= HP:0002425<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 3<br><b>shape<\\/b>= database<br><b>name<\\/b>= Anarthria<br>\",\"<b>node<\\/b>= Poor coordination<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0.004<br><b>CellType<\\/b>= Fetus_Mast_cell<br><b>ancestor_name<\\/b>= Abnormality of the nervous system<br><b>disease_id<\\/b>= OMIM:616878<br><b>ontLvl<\\/b>= 7<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Poor coordination<br><b>hpo_id<\\/b>= HP:0002370<br><b>disease_name<\\/b>= Metabolic encephalomyopathic crises, recurrent, with\\nrhabdomyolysis, cardiac arrhythmias, and neurodegeneration<br><b>shape<\\/b>= database<br><b>name<\\/b>= Poor coordination<br>\",\"<b>node<\\/b>= Unconjugated hyperbilirubinemia<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Erythroblasts<br><b>ancestor_name<\\/b>= Abnormality of metabolism/homeostasis<br><b>disease_id<\\/b>= OMIM:618278<br><b>ontLvl<\\/b>= 9<br><b>definition<\\/b>= An increased amount of unconjugated (indirect) bilurubin in\\nthe blood.<br><b>hpo_name<\\/b>= Unconjugated hyperbilirubinemia<br><b>hpo_id<\\/b>= HP:0008282<br><b>disease_name<\\/b>= Fibrosis, neurodegeneration, and cerebral angiomatosis<br><b>shape<\\/b>= database<br><b>name<\\/b>= Unconjugated hyperbilirubinemia<br>\",\"<b>node<\\/b>= Laryngeal dystonia<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_M2_Macrophage<br><b>ancestor_name<\\/b>= Abnormality of the nervous system<br><b>disease_id<\\/b>= OMIM:606159<br><b>ontLvl<\\/b>= 7<br><b>definition<\\/b>= A form of focal dystonia that affects the vocal cords,\\nassociated with involuntary contractions of the vocal cords\\ncausing interruptions of speech and affecting the voice\\nquality and often leading to patterned, repeated breaks in\\nspeech.<br><b>hpo_name<\\/b>= Laryngeal dystonia<br><b>hpo_id<\\/b>= HP:0012049<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 3<br><b>shape<\\/b>= database<br><b>name<\\/b>= Laryngeal dystonia<br>\",\"<b>node<\\/b>= Elevated urine acetoacetic acid level<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_Immature_sertoli_cell_(Pre_Sertoli_cell)<br><b>ancestor_name<\\/b>= Abnormality of the genitourinary system<br><b>disease_id<\\/b>= OMIM:620089<br><b>ontLvl<\\/b>= 8<br><b>definition<\\/b>= Elevated amount of acetoacetic acid in the urine.<br><b>hpo_name<\\/b>= Elevated urine acetoacetic acid level<br><b>hpo_id<\\/b>= HP:0033407<br><b>disease_name<\\/b>= Neurodegeneration, childhood-onset, with multisystem\\ninvolvement due to mitochondrial dysfunction<br><b>shape<\\/b>= database<br><b>name<\\/b>= Elevated urine acetoacetic acid level<br>\",\"<b>node<\\/b>= Hepatocellular necrosis<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= HESC_Proliferating_T_cell<br><b>ancestor_name<\\/b>= Abnormality of the digestive system<br><b>disease_id<\\/b>= OMIM:618278<br><b>ontLvl<\\/b>= 7<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Hepatocellular necrosis<br><b>hpo_id<\\/b>= HP:0001404<br><b>disease_name<\\/b>= Fibrosis, neurodegeneration, and cerebral angiomatosis<br><b>shape<\\/b>= database<br><b>name<\\/b>= Hepatocellular necrosis<br>\",\"<b>node<\\/b>= Upgaze palsy<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0.018<br><b>CellType<\\/b>= Fetus_Monocyte<br><b>ancestor_name<\\/b>= Abnormality of the eye<br><b>disease_id<\\/b>= OMIM:618276<br><b>ontLvl<\\/b>= 8<br><b>definition<\\/b>= A limitation of the ability to direct one's gaze above the\\nhorizontal meridian.<br><b>hpo_name<\\/b>= Upgaze palsy<br><b>hpo_id<\\/b>= HP:0025331<br><b>disease_name<\\/b>= Neurodegeneration, childhood-onset, with cerebellar atrophy<br><b>shape<\\/b>= database<br><b>name<\\/b>= Upgaze palsy<br>\",\"<b>node<\\/b>= Decreased circulating ferritin concentration<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_M2_Macrophage<br><b>ancestor_name<\\/b>= Abnormality of metabolism/homeostasis<br><b>disease_id<\\/b>= OMIM:606159<br><b>ontLvl<\\/b>= 6<br><b>definition<\\/b>= Abnormally reduced concentration of ferritin, a ubiquitous\\nintracellular protein that stores iron, in the blood.<br><b>hpo_name<\\/b>= Decreased circulating ferritin concentration<br><b>hpo_id<\\/b>= HP:0012343<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 3<br><b>shape<\\/b>= database<br><b>name<\\/b>= Decreased circulating ferritin concentration<br>\",\"<b>node<\\/b>= Sclerotic vertebral body<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Microglia<br><b>ancestor_name<\\/b>= Abnormality of the musculoskeletal system<br><b>disease_id<\\/b>= OMIM:618476<br><b>ontLvl<\\/b>= 8<br><b>definition<\\/b>= Increase in bone density of the vertebral body.<br><b>hpo_name<\\/b>= Sclerotic vertebral body<br><b>hpo_id<\\/b>= HP:0100861<br><b>disease_name<\\/b>= Brain abnormalities, neurodegeneration, and\\ndysosteosclerosis<br><b>shape<\\/b>= database<br><b>name<\\/b>= Sclerotic vertebral body<br>\",\"<b>node<\\/b>= basal cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.034<br><b>CellType<\\/b>= Fetus_Basal_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620089<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Opto-chiasmatic atrophy<br><b>hpo_id<\\/b>= HP:0034008<br><b>disease_name<\\/b>= Neurodegeneration, childhood-onset, with multisystem\\ninvolvement due to mitochondrial dysfunction<br><b>shape<\\/b>= circle<br><b>name<\\/b>= basal cell<br>\",\"<b>node<\\/b>= alternatively activated macrophage<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_M2_Macrophage<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:606159<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Cavitation of the basal ganglia<br><b>hpo_id<\\/b>= HP:0007007<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 3<br><b>shape<\\/b>= circle<br><b>name<\\/b>= alternatively activated macrophage<br>\",\"<b>node<\\/b>= macrophage<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.005<br><b>CellType<\\/b>= Fetus_Macrophage<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:606159<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Cavitation of the basal ganglia<br><b>hpo_id<\\/b>= HP:0007007<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 3<br><b>shape<\\/b>= circle<br><b>name<\\/b>= macrophage<br>\",\"<b>node<\\/b>= embryonic stem cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.01<br><b>CellType<\\/b>= Adult_hESC<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620327<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Dysgyria<br><b>hpo_id<\\/b>= HP:0032398<br><b>disease_name<\\/b>= Neurodegeneration with developmental delay, early\\nrespiratory failure, myoclonic seizures, and brain\\nabnormalities<br><b>shape<\\/b>= circle<br><b>name<\\/b>= embryonic stem cell<br>\",\"<b>node<\\/b>= endocrine cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.033<br><b>CellType<\\/b>= Fetus_Gastric_endocrine_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:234200<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Cerebral degeneration<br><b>hpo_id<\\/b>= HP:0007313<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 1<br><b>shape<\\/b>= circle<br><b>name<\\/b>= endocrine cell<br>\",\"<b>node<\\/b>= primordial germ cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.021<br><b>CellType<\\/b>= Adult_Primordial_germ_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:234200<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Eye of the tiger anomaly of globus pallidus<br><b>hpo_id<\\/b>= HP:0002454<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 1<br><b>shape<\\/b>= circle<br><b>name<\\/b>= primordial germ cell<br>\",\"<b>node<\\/b>= mast cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.004<br><b>CellType<\\/b>= Fetus_Mast_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:616878<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Poor coordination<br><b>hpo_id<\\/b>= HP:0002370<br><b>disease_name<\\/b>= Metabolic encephalomyopathic crises, recurrent, with\\nrhabdomyolysis, cardiac arrhythmias, and neurodegeneration<br><b>shape<\\/b>= circle<br><b>name<\\/b>= mast cell<br>\",\"<b>node<\\/b>= erythroblast<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Erythroblasts<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:618278<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Unconjugated hyperbilirubinemia<br><b>hpo_id<\\/b>= HP:0008282<br><b>disease_name<\\/b>= Fibrosis, neurodegeneration, and cerebral angiomatosis<br><b>shape<\\/b>= circle<br><b>name<\\/b>= erythroblast<br>\",\"<b>node<\\/b>= Sertoli cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_Immature_sertoli_cell_(Pre_Sertoli_cell)<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620089<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Elevated urine acetoacetic acid level<br><b>hpo_id<\\/b>= HP:0033407<br><b>disease_name<\\/b>= Neurodegeneration, childhood-onset, with multisystem\\ninvolvement due to mitochondrial dysfunction<br><b>shape<\\/b>= circle<br><b>name<\\/b>= Sertoli cell<br>\",\"<b>node<\\/b>= T cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= HESC_Proliferating_T_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:618278<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Hepatocellular necrosis<br><b>hpo_id<\\/b>= HP:0001404<br><b>disease_name<\\/b>= Fibrosis, neurodegeneration, and cerebral angiomatosis<br><b>shape<\\/b>= circle<br><b>name<\\/b>= T cell<br>\",\"<b>node<\\/b>= monocyte<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.018<br><b>CellType<\\/b>= Fetus_Monocyte<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:618276<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Upgaze palsy<br><b>hpo_id<\\/b>= HP:0025331<br><b>disease_name<\\/b>= Neurodegeneration, childhood-onset, with cerebellar atrophy<br><b>shape<\\/b>= circle<br><b>name<\\/b>= monocyte<br>\",\"<b>node<\\/b>= microglial cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Microglia<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:618476<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Sclerotic vertebral body<br><b>hpo_id<\\/b>= HP:0100861<br><b>disease_name<\\/b>= Brain abnormalities, neurodegeneration, and\\ndysosteosclerosis<br><b>shape<\\/b>= circle<br><b>name<\\/b>= microglial cell<br>\",\"<b>node<\\/b>= myeloid cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.001<br><b>CellType<\\/b>= Myeloid_cells<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:618476<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Sclerotic vertebral body<br><b>hpo_id<\\/b>= HP:0100861<br><b>disease_name<\\/b>= Brain abnormalities, neurodegeneration, and\\ndysosteosclerosis<br><b>shape<\\/b>= circle<br><b>name<\\/b>= myeloid cell<br>\",\"<b>node<\\/b>= renal intercalated cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.021<br><b>CellType<\\/b>= Fetus_Kidney_intercalated_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:618476<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Sclerotic vertebral body<br><b>hpo_id<\\/b>= HP:0100861<br><b>disease_name<\\/b>= Brain abnormalities, neurodegeneration, and\\ndysosteosclerosis<br><b>shape<\\/b>= circle<br><b>name<\\/b>= renal intercalated cell<br>\",\"<b>node<\\/b>= LETM1<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0.034<br><b>CellType<\\/b>= Fetus_Basal_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620089<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Opto-chiasmatic atrophy<br><b>hpo_id<\\/b>= HP:0034008<br><b>disease_name<\\/b>= Neurodegeneration, childhood-onset, with multisystem\\ninvolvement due to mitochondrial dysfunction<br><b>shape<\\/b>= box<br><b>name<\\/b>= LETM1<br>\",\"<b>node<\\/b>= FTL<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_M2_Macrophage<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:606159<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Cavitation of the basal ganglia<br><b>hpo_id<\\/b>= HP:0007007<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 3<br><b>shape<\\/b>= box<br><b>name<\\/b>= FTL<br>\",\"<b>node<\\/b>= MED11<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0.01<br><b>CellType<\\/b>= Adult_hESC<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:620327<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Dysgyria<br><b>hpo_id<\\/b>= HP:0032398<br><b>disease_name<\\/b>= Neurodegeneration with developmental delay, early\\nrespiratory failure, myoclonic seizures, and brain\\nabnormalities<br><b>shape<\\/b>= box<br><b>name<\\/b>= MED11<br>\",\"<b>node<\\/b>= PANK2<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0.033<br><b>CellType<\\/b>= Fetus_Gastric_endocrine_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:234200<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Cerebral degeneration<br><b>hpo_id<\\/b>= HP:0007313<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 1<br><b>shape<\\/b>= box<br><b>name<\\/b>= PANK2<br>\",\"<b>node<\\/b>= C19orf12<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0.021<br><b>CellType<\\/b>= Adult_Primordial_germ_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:614298<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Eye of the tiger anomaly of globus pallidus<br><b>hpo_id<\\/b>= HP:0002454<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 4<br><b>shape<\\/b>= box<br><b>name<\\/b>= C19orf12<br>\",\"<b>node<\\/b>= PLA2G6<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0.018<br><b>CellType<\\/b>= Fetus_M2_Macrophage<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:610217<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Neurofibrillary tangles<br><b>hpo_id<\\/b>= HP:0002185<br><b>disease_name<\\/b>= Neurodegeneration with brain iron accumulation 2B<br><b>shape<\\/b>= box<br><b>name<\\/b>= PLA2G6<br>\",\"<b>node<\\/b>= CSF1R<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0.015<br><b>CellType<\\/b>= Fetus_Macrophage<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:618476<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Increased skull ossification<br><b>hpo_id<\\/b>= HP:0004330<br><b>disease_name<\\/b>= Brain abnormalities, neurodegeneration, and\\ndysosteosclerosis<br><b>shape<\\/b>= box<br><b>name<\\/b>= CSF1R<br>\",\"<b>node<\\/b>= TANGO2<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0.004<br><b>CellType<\\/b>= Fetus_Mast_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:616878<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Poor coordination<br><b>hpo_id<\\/b>= HP:0002370<br><b>disease_name<\\/b>= Metabolic encephalomyopathic crises, recurrent, with\\nrhabdomyolysis, cardiac arrhythmias, and neurodegeneration<br><b>shape<\\/b>= box<br><b>name<\\/b>= TANGO2<br>\",\"<b>node<\\/b>= NHLRC2<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Erythroblasts<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:618278<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Unconjugated hyperbilirubinemia<br><b>hpo_id<\\/b>= HP:0008282<br><b>disease_name<\\/b>= Fibrosis, neurodegeneration, and cerebral angiomatosis<br><b>shape<\\/b>= box<br><b>name<\\/b>= NHLRC2<br>\",\"<b>node<\\/b>= AGTPBP1<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0.018<br><b>CellType<\\/b>= Fetus_Monocyte<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:618276<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Upgaze palsy<br><b>hpo_id<\\/b>= HP:0025331<br><b>disease_name<\\/b>= Neurodegeneration, childhood-onset, with cerebellar atrophy<br><b>shape<\\/b>= box<br><b>name<\\/b>= AGTPBP1<br>\"],\"degree\":[4,16,2,4,2,2,12,2,4,2,2,6,2,2,3,2,2,2,4,2,2,2,2,2,2,2,10,3,24,12,3,3,5,3,3,3,3,3,3,3,3,2,8,1,2,1,1,6,1,2,1],\"value\":[21,9,23,21,23,23,13,23,21,23,23,19,23,23,22,23,23,23,21,23,23,23,23,23,23,23,15,22,1,13,22,22,20,22,22,22,22,22,22,22,22,23,17,24,23,24,24,19,24,23,24],\"color\":[\"#000C7D\",\"#000C7D\",\"#000C7D\",\"#000C7D\",\"#000C7D\",\"#000C7D\",\"#000C7D\",\"#000C7D\",\"#000C7D\",\"#000C7D\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FFF123\",\"#FFF123\",\"#FFF123\",\"#FFF123\",\"#FFF123\",\"#FFF123\",\"#FFF123\",\"#FFF123\",\"#FFF123\",\"#FFF123\"],\"label\":[\"Neurodegeneration,\\nchildhood-onset,\\nwith\\nmultisystem\\ninvolvement\\ndue to\\nmitochondrial\\ndysfunction\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration\\nwith\\ndevelopmental\\ndelay,\\nearly\\nrespiratory\\nfailure,\\nmyoclonic\\nseizures,\\nand brain\\nabnormalities\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n1\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n4\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n2B\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\",\"Metabolic\\nencephalomyopathic\\ncrises,\\nrecurrent,\\nwith\\nrhabdomyolysis,\\ncardiac\\narrhythmias,\\nand\\nneurodegeneration\",\"Fibrosis,\\nneurodegeneration,\\nand\\ncerebral\\nangiomatosis\",\"Neurodegeneration,\\nchildhood-onset,\\nwith\\ncerebellar\\natrophy\",\"Opto-chiasmatic\\natrophy\",\"Cavitation\\nof the\\nbasal\\nganglia\",\"Dysgyria\",\"Cerebral\\ndegeneration\",\"Eye of\\nthe tiger\\nanomaly\\nof globus\\npallidus\",\"Neurofibrillary\\ntangles\",\"Increased\\nskull\\nossification\",\"Micrographia\",\"Anarthria\",\"Poor\\ncoordination\",\"Unconjugated\\nhyperbilirubinemia\",\"Laryngeal\\ndystonia\",\"Elevated\\nurine\\nacetoacetic\\nacid level\",\"Hepatocellular\\nnecrosis\",\"Upgaze\\npalsy\",\"Decreased\\ncirculating\\nferritin\\nconcentration\",\"Sclerotic\\nvertebral\\nbody\",\"basal cell\",\"alternatively\\nactivated\\nmacrophage\",\"macrophage\",\"embryonic\\nstem cell\",\"endocrine\\ncell\",\"primordial\\ngerm cell\",\"mast cell\",\"erythroblast\",\"Sertoli\\ncell\",\"T cell\",\"monocyte\",\"microglial\\ncell\",\"myeloid\\ncell\",\"renal\\nintercalated\\ncell\",\"LETM1\",\"FTL\",\"MED11\",\"PANK2\",\"C19orf12\",\"PLA2G6\",\"CSF1R\",\"TANGO2\",\"NHLRC2\",\"AGTPBP1\"],\"x\":[-0.926829268292683,-0.3658536585365854,0.3658536585365855,0.5121951219512195,0.6097560975609757,-0.7317073170731707,0.1951219512195121,0.7073170731707317,0.8536585365853659,1,-1,-0.1463414634146342,0.3414634146341464,0.4390243902439024,0.5853658536585367,-0.7317073170731707,-0.09756097560975607,-0.3414634146341463,-0.1951219512195121,0.6829268292682926,0.7804878048780488,-0.5853658536585367,-0.9024390243902439,0.8780487804878048,0.975609756097561,-0.7804878048780488,0.1951219512195121,-0.975609756097561,-0.4146341463414634,0.02439024390243905,0.3658536585365855,0.4634146341463414,0.5853658536585367,0.7073170731707317,0.8048780487804879,-0.8780487804878049,0.9024390243902438,1,0.1707317073170731,0.2926829268292683,0.2195121951219512,-0.926829268292683,-0.3902439024390244,0.3658536585365855,0.4634146341463414,0.5853658536585367,-0.4390243902439024,0.09756097560975618,0.7073170731707317,0.8536585365853659,1],\"y\":[-1,-1,-1,-1,-1,-1,-1,-1,-1,-1,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,1,1,1,1,1,1,1,1,1,1]},\"edges\":{\"from\":[\"Neurodegeneration,\\nchildhood-onset,\\nwith\\nmultisystem\\ninvolvement\\ndue to\\nmitochondrial\\ndysfunction\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration\\nwith\\ndevelopmental\\ndelay,\\nearly\\nrespiratory\\nfailure,\\nmyoclonic\\nseizures,\\nand brain\\nabnormalities\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n1\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n1\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n4\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n2B\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Metabolic\\nencephalomyopathic\\ncrises,\\nrecurrent,\\nwith\\nrhabdomyolysis,\\ncardiac\\narrhythmias,\\nand\\nneurodegeneration\",\"Fibrosis,\\nneurodegeneration,\\nand\\ncerebral\\nangiomatosis\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration,\\nchildhood-onset,\\nwith\\nmultisystem\\ninvolvement\\ndue to\\nmitochondrial\\ndysfunction\",\"Fibrosis,\\nneurodegeneration,\\nand\\ncerebral\\nangiomatosis\",\"Neurodegeneration,\\nchildhood-onset,\\nwith\\ncerebellar\\natrophy\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\",\"Opto-chiasmatic\\natrophy\",\"Cavitation\\nof the\\nbasal\\nganglia\",\"Cavitation\\nof the\\nbasal\\nganglia\",\"Cavitation\\nof the\\nbasal\\nganglia\",\"Dysgyria\",\"Cerebral\\ndegeneration\",\"Eye of\\nthe tiger\\nanomaly\\nof globus\\npallidus\",\"Neurofibrillary\\ntangles\",\"Increased\\nskull\\nossification\",\"Micrographia\",\"Anarthria\",\"Anarthria\",\"Poor\\ncoordination\",\"Unconjugated\\nhyperbilirubinemia\",\"Laryngeal\\ndystonia\",\"Elevated\\nurine\\nacetoacetic\\nacid level\",\"Hepatocellular\\nnecrosis\",\"Upgaze\\npalsy\",\"Decreased\\ncirculating\\nferritin\\nconcentration\",\"Sclerotic\\nvertebral\\nbody\",\"Sclerotic\\nvertebral\\nbody\",\"Sclerotic\\nvertebral\\nbody\",\"Sclerotic\\nvertebral\\nbody\",\"Sclerotic\\nvertebral\\nbody\",\"basal cell\",\"alternatively\\nactivated\\nmacrophage\",\"alternatively\\nactivated\\nmacrophage\",\"macrophage\",\"embryonic\\nstem cell\",\"endocrine\\ncell\",\"primordial\\ngerm cell\",\"primordial\\ngerm cell\",\"alternatively\\nactivated\\nmacrophage\",\"macrophage\",\"alternatively\\nactivated\\nmacrophage\",\"alternatively\\nactivated\\nmacrophage\",\"alternatively\\nactivated\\nmacrophage\",\"mast cell\",\"erythroblast\",\"alternatively\\nactivated\\nmacrophage\",\"Sertoli\\ncell\",\"T cell\",\"monocyte\",\"alternatively\\nactivated\\nmacrophage\",\"microglial\\ncell\",\"macrophage\",\"macrophage\",\"myeloid\\ncell\",\"renal\\nintercalated\\ncell\",\"Neurodegeneration,\\nchildhood-onset,\\nwith\\nmultisystem\\ninvolvement\\ndue to\\nmitochondrial\\ndysfunction\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration\\nwith\\ndevelopmental\\ndelay,\\nearly\\nrespiratory\\nfailure,\\nmyoclonic\\nseizures,\\nand brain\\nabnormalities\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n1\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n1\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n4\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n2B\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Metabolic\\nencephalomyopathic\\ncrises,\\nrecurrent,\\nwith\\nrhabdomyolysis,\\ncardiac\\narrhythmias,\\nand\\nneurodegeneration\",\"Fibrosis,\\nneurodegeneration,\\nand\\ncerebral\\nangiomatosis\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Neurodegeneration,\\nchildhood-onset,\\nwith\\nmultisystem\\ninvolvement\\ndue to\\nmitochondrial\\ndysfunction\",\"Fibrosis,\\nneurodegeneration,\\nand\\ncerebral\\nangiomatosis\",\"Neurodegeneration,\\nchildhood-onset,\\nwith\\ncerebellar\\natrophy\",\"Neurodegeneration\\nwith\\nbrain iron\\naccumulation\\n3\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\",\"Brain\\nabnormalities,\\nneurodegeneration,\\nand\\ndysosteosclerosis\"],\"to\":[\"Opto-chiasmatic\\natrophy\",\"Cavitation\\nof the\\nbasal\\nganglia\",\"Cavitation\\nof the\\nbasal\\nganglia\",\"Cavitation\\nof the\\nbasal\\nganglia\",\"Dysgyria\",\"Cerebral\\ndegeneration\",\"Eye of\\nthe tiger\\nanomaly\\nof globus\\npallidus\",\"Eye of\\nthe tiger\\nanomaly\\nof globus\\npallidus\",\"Neurofibrillary\\ntangles\",\"Increased\\nskull\\nossification\",\"Micrographia\",\"Anarthria\",\"Anarthria\",\"Poor\\ncoordination\",\"Unconjugated\\nhyperbilirubinemia\",\"Laryngeal\\ndystonia\",\"Elevated\\nurine\\nacetoacetic\\nacid level\",\"Hepatocellular\\nnecrosis\",\"Upgaze\\npalsy\",\"Decreased\\ncirculating\\nferritin\\nconcentration\",\"Sclerotic\\nvertebral\\nbody\",\"Sclerotic\\nvertebral\\nbody\",\"Sclerotic\\nvertebral\\nbody\",\"Sclerotic\\nvertebral\\nbody\",\"Sclerotic\\nvertebral\\nbody\",\"basal cell\",\"alternatively\\nactivated\\nmacrophage\",\"alternatively\\nactivated\\nmacrophage\",\"macrophage\",\"embryonic\\nstem cell\",\"endocrine\\ncell\",\"primordial\\ngerm cell\",\"alternatively\\nactivated\\nmacrophage\",\"macrophage\",\"alternatively\\nactivated\\nmacrophage\",\"alternatively\\nactivated\\nmacrophage\",\"alternatively\\nactivated\\nmacrophage\",\"mast cell\",\"erythroblast\",\"alternatively\\nactivated\\nmacrophage\",\"Sertoli\\ncell\",\"T cell\",\"monocyte\",\"alternatively\\nactivated\\nmacrophage\",\"microglial\\ncell\",\"macrophage\",\"macrophage\",\"myeloid\\ncell\",\"renal\\nintercalated\\ncell\",\"LETM1\",\"FTL\",\"FTL\",\"FTL\",\"MED11\",\"PANK2\",\"PANK2\",\"C19orf12\",\"PLA2G6\",\"CSF1R\",\"FTL\",\"FTL\",\"FTL\",\"TANGO2\",\"NHLRC2\",\"FTL\",\"LETM1\",\"NHLRC2\",\"AGTPBP1\",\"FTL\",\"CSF1R\",\"CSF1R\",\"CSF1R\",\"CSF1R\",\"CSF1R\",\"basal cell\",\"alternatively\\nactivated\\nmacrophage\",\"alternatively\\nactivated\\nmacrophage\",\"macrophage\",\"embryonic\\nstem cell\",\"endocrine\\ncell\",\"primordial\\ngerm cell\",\"primordial\\ngerm cell\",\"alternatively\\nactivated\\nmacrophage\",\"macrophage\",\"alternatively\\nactivated\\nmacrophage\",\"alternatively\\nactivated\\nmacrophage\",\"alternatively\\nactivated\\nmacrophage\",\"mast cell\",\"erythroblast\",\"alternatively\\nactivated\\nmacrophage\",\"Sertoli\\ncell\",\"T cell\",\"monocyte\",\"alternatively\\nactivated\\nmacrophage\",\"microglial\\ncell\",\"macrophage\",\"macrophage\",\"myeloid\\ncell\",\"renal\\nintercalated\\ncell\"],\"color\":[0.6154701306353643,0.8418733422394665,0.8418733422394665,0.8418733422394665,0.6688509053236619,0.6171258365394181,0.6362497305663646,0.6362497305663646,0.6440721426627625,0.651216453479359,0.6503526834462821,0.6915296149012446,0.6915296149012446,0.7066286623637668,1.840095210807251,0.8314160249972958,1.079913469870557,0.9198022483322049,0.6449577071586498,0.8900847090442254,0.8466878896599308,0.8466878896599308,0.8466878896599308,0.8466878896599308,0.8466878896599308,0.6154701306353643,0.9160004043337231,0.9160004043337231,0.6936192180509532,0.6688509053236619,0.6171258365394181,0.6362497305663646,0.6440721426627625,0.651216453479359,0.6503526834462821,0.6915296149012446,0.6915296149012446,0.7066286623637668,1.840095210807251,0.8314160249972958,1.079913469870557,0.9198022483322049,0.6449577071586498,0.8900847090442254,1.064280025405704,0.895017571781288,0.895017571781288,0.7413307305411636,0.6377935487902099,0.6154701306353643,0.8257167583090416,0.8257167583090416,0.6936192180509532,0.6688509053236619,0.6171258365394181,0.6362497305663646,0.6362497305663646,0.6440721426627625,0.8137505323473118,0.8257167583090416,0.8257167583090416,0.8257167583090416,0.7066286623637668,1.840095210807251,0.8257167583090416,1.079913469870557,0.9198022483322049,0.6449577071586498,0.8257167583090416,1.064280025405704,0.8137505323473118,0.8137505323473118,0.7413307305411636,0.6377935487902099,0.6154701306353643,0.8257167583090416,0.8257167583090416,0.6936192180509532,0.6688509053236619,0.6171258365394181,0.6362497305663646,0.6362497305663646,0.6440721426627625,0.8137505323473118,0.8257167583090416,0.8257167583090416,0.8257167583090416,0.7066286623637668,1.840095210807251,0.8257167583090416,1.079913469870557,0.9198022483322049,0.6449577071586498,0.8257167583090416,1.064280025405704,0.8137505323473118,0.8137505323473118,0.7413307305411636,0.6377935487902099],\"width\":[0.6154701306353643,0.9975245705101743,0.834476238157272,0.6936192180509532,0.6688509053236619,0.6171258365394181,0.6362497305663646,0.6362497305663646,0.6440721426627625,0.651216453479359,0.6503526834462821,0.7850335947073154,0.598025635095174,0.7066286623637668,1.840095210807251,0.8314160249972958,1.079913469870557,0.9198022483322049,0.6449577071586498,0.8900847090442254,1.064280025405704,0.9619886909709897,0.8280464525915865,0.7413307305411636,0.6377935487902099,0.6154701306353643,0.9975245705101743,0.834476238157272,0.6936192180509532,0.6688509053236619,0.6171258365394181,0.6362497305663646,0.6440721426627625,0.651216453479359,0.6503526834462821,0.7850335947073154,0.598025635095174,0.7066286623637668,1.840095210807251,0.8314160249972958,1.079913469870557,0.9198022483322049,0.6449577071586498,0.8900847090442254,1.064280025405704,0.9619886909709897,0.8280464525915865,0.7413307305411636,0.6377935487902099,0.6154701306353643,0.9975245705101743,0.834476238157272,0.6936192180509532,0.6688509053236619,0.6171258365394181,0.6362497305663646,0.6362497305663646,0.6440721426627625,0.651216453479359,0.6503526834462821,0.7850335947073154,0.598025635095174,0.7066286623637668,1.840095210807251,0.8314160249972958,1.079913469870557,0.9198022483322049,0.6449577071586498,0.8900847090442254,1.064280025405704,0.9619886909709897,0.8280464525915865,0.7413307305411636,0.6377935487902099,0.6154701306353643,0.9975245705101743,0.834476238157272,0.6936192180509532,0.6688509053236619,0.6171258365394181,0.6362497305663646,0.6362497305663646,0.6440721426627625,0.651216453479359,0.6503526834462821,0.7850335947073154,0.598025635095174,0.7066286623637668,1.840095210807251,0.8314160249972958,1.079913469870557,0.9198022483322049,0.6449577071586498,0.8900847090442254,1.064280025405704,0.9619886909709897,0.8280464525915865,0.7413307305411636,0.6377935487902099]},\"nodesToDataframe\":true,\"edgesToDataframe\":true,\"options\":{\"width\":\"100%\",\"height\":\"100%\",\"nodes\":{\"shape\":\"dot\",\"physics\":false,\"borderWidth\":3,\"borderWidthSelected\":6,\"color\":{\"hover\":{\"background\":\"rgba(0,0,0,.5)\"},\"highlight\":{\"background\":\"#00FFFFCF\",\"border\":\"#00FFFFCF\"}},\"opacity\":0.75,\"font\":{\"color\":\"#F0FFFF\",\"strokeWidth\":2,\"strokeColor\":\"rgba(0,0,0,1)\"},\"shadow\":{\"enabled\":true,\"size\":10}},\"manipulation\":{\"enabled\":false},\"edges\":{\"arrows\":\"from\",\"color\":{\"opacity\":0.5},\"smooth\":{\"enabled\":true,\"type\":\"cubicBezier\",\"roundness\":0.5},\"shadow\":{\"enabled\":false}},\"physics\":{\"solver\":\"forceAtlas2Based\",\"enabled\":false,\"forceAtlas2Based\":{\"avoidOverlap\":0.5,\"gravitationalConstant\":-50}},\"interaction\":{\"hover\":true,\"zoomSpeed\":1}},\"groups\":null,\"width\":\"100%\",\"height\":\"60vh\",\"idselection\":{\"enabled\":false,\"style\":\"width: 150px; height: 26px\",\"useLabels\":true,\"main\":\"Select by id\"},\"byselection\":{\"enabled\":false,\"style\":\"width: 150px; height: 26px\",\"multiple\":false,\"hideColor\":\"rgba(200,200,200,0.5)\",\"highlight\":false,\"variable\":\"name\",\"main\":\"Select by name\"},\"main\":{\"text\":\"neurodegeneration\",\"style\":\"font-family:Georgia, Times New Roman, Times, serif;font-weight:bold;font-size:20px;text-align:center;\"},\"submain\":null,\"footer\":null,\"background\":\"transparent\",\"igraphlayout\":{\"type\":\"full\"},\"tooltipStay\":300,\"tooltipStyle\":\"position: fixed;visibility:hidden;padding: 5px;white-space: nowrap;font-family: verdana;font-size:14px;font-color:#000000;background-color: #f5f4ed;-moz-border-radius: 3px;-webkit-border-radius: 3px;border-radius: 3px;border: 1px solid #808074;box-shadow: 3px 3px 10px rgba(0, 0, 0, 0.2);\",\"highlight\":{\"enabled\":true,\"hoverNearest\":false,\"degree\":1,\"algorithm\":\"all\",\"hideColor\":\"rgba(200,200,200,0.5)\",\"labelOnly\":true},\"collapse\":{\"enabled\":false,\"fit\":false,\"resetHighlight\":true,\"clusterOptions\":null,\"keepCoord\":true,\"labelSuffix\":\"(cluster)\"},\"events\":{\"doubleClick\":\"function(){ this.fit()}\"}},\"evals\":[\"events.doubleClick\"],\"jsHooks\":[]}</script>\n```\n\n\nParkinson disease\n\n```{.r .cell-code .hidden}\n#| label: fig-therapy-examples-supp\n#| layout: [[1,1], [1,1]]\n#| fig-cap: Example cell type-specific gene therapy targets for several severe phenotypes and their associated diseases. Each disease (blue cylinders) is connected to its phenotype (purple cylinders) based on well-established clinical observations recorded within the HPO [@Gargano2024-fc].Phenotypes are connected to cell types (red circles) via association testing between weighted gene sets ($FDR_{p,c}<0.05$). Each cell type is connected to the prioritised gene targets (yellow boxes) based on the driver gene analysis.The thickness of the edges connecting the nodes represent the (mean) fold-change from the bootstrapped enrichment tests. Nodes were spatially arranged using the Sugiyama algorithm [@Sugiyama1981-ev].\n#| fig-subcap:\n#| - 'Respiratory failure'\n#| - 'Alzheimer disease'\n#| - 'Parkinson disease'\n\nvn_therapy_eg4$plot\n```\n\n```{=html}\n<div id=\"htmlwidget-9fa4a9d2dff0dbd94e94\" style=\"width:100%;height:60vh;\" class=\"visNetwork html-widget\"></div>\n<script type=\"application/json\" data-for=\"htmlwidget-9fa4a9d2dff0dbd94e94\">{\"x\":{\"nodes\":{\"id\":[\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Retinal\\narteriolar\\ntortuosity\",\"Polycoria\",\"Facial\\nparalysis\",\"endothelial\\ncell\",\"stromal\\ncell\",\"fibroblast\",\"skeletal\\nmuscle\\nsatellite\\ncell\",\"smooth\\nmuscle\\ncell\",\"mesenchymal\\nstem cell\",\"COL4A1\"],\"node\":[\"Brain small vessel disease 1 with or without ocular anomalies\",\"Retinal arteriolar tortuosity\",\"Polycoria\",\"Facial paralysis\",\"endothelial cell\",\"stromal cell\",\"fibroblast\",\"skeletal muscle satellite cell\",\"smooth muscle cell\",\"mesenchymal stem cell\",\"COL4A1\"],\"node_type\":[\"disease_name\",\"hpo_name\",\"hpo_name\",\"hpo_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"cl_name\",\"gene_symbol\"],\"q\":[0.0127702302889777,0.0127702302889777,1.12248366188673e-24,3.4825007588296e-17,0.0127702302889777,1.12248366188673e-24,7.91185906587398e-18,0.0181371925253845,0.0319686172203034,3.4825007588296e-17,0.0127702302889777],\"CellType\":[\"Adult_Endothelial_cell_(endothelial_to_mesenchymal_transition)\",\"Adult_Endothelial_cell_(endothelial_to_mesenchymal_transition)\",\"Fetus_Stromal_cell\",\"Adult_Fetal_mesenchymal_progenitor\",\"Adult_Endothelial_cell_(endothelial_to_mesenchymal_transition)\",\"Fetus_Stromal_cell\",\"Fetus_Fibroblast\",\"Satellite_cells\",\"Smooth_muscle_cells\",\"Adult_Fetal_mesenchymal_progenitor\",\"Adult_Endothelial_cell_(endothelial_to_mesenchymal_transition)\"],\"ancestor_name\":[null,\"Abnormality of head or neck\",\"Abnormality of the eye\",\"Abnormality of head or neck\",null,null,null,null,null,null,null],\"disease_id\":[\"OMIM:175780\",\"OMIM:175780\",\"OMIM:175780\",\"OMIM:175780\",\"OMIM:175780\",\"OMIM:175780\",\"OMIM:175780\",\"OMIM:175780\",\"OMIM:175780\",\"OMIM:175780\",\"OMIM:175780\"],\"ontLvl\":[null,9,7,8,null,null,null,null,null,null,null],\"definition\":[null,\"The presence of an increased number of twists and turns of the retinal arterioles.\",\"Multiple pupils.\",\"Complete loss of ability to move facial muscles innervated by the facial nerve (i.e., the seventh cranial nerve).\",null,null,null,null,null,null,null],\"hpo_name\":[\"Retinal arteriolar tortuosity\",\"Retinal arteriolar tortuosity\",\"Polycoria\",\"Facial paralysis\",\"Retinal arteriolar tortuosity\",\"Polycoria\",\"Polycoria\",\"Polycoria\",\"Polycoria\",\"Facial paralysis\",\"Retinal arteriolar tortuosity\"],\"hpo_id\":[\"HP:0001136\",\"HP:0001136\",\"HP:0011500\",\"HP:0007209\",\"HP:0001136\",\"HP:0011500\",\"HP:0011500\",\"HP:0011500\",\"HP:0011500\",\"HP:0007209\",\"HP:0001136\"],\"disease_name\":[\"Brain small vessel disease 1 with or without ocular anomalies\",\"Brain small vessel disease 1 with or without ocular anomalies\",\"Brain small vessel disease 1 with or without ocular anomalies\",\"Brain small vessel disease 1 with or without ocular anomalies\",\"Brain small vessel disease 1 with or without ocular anomalies\",\"Brain small vessel disease 1 with or without ocular anomalies\",\"Brain small vessel disease 1 with or without ocular anomalies\",\"Brain small vessel disease 1 with or without ocular anomalies\",\"Brain small vessel disease 1 with or without ocular anomalies\",\"Brain small vessel disease 1 with or without ocular anomalies\",\"Brain small vessel disease 1 with or without ocular anomalies\"],\"shape\":[\"database\",\"database\",\"database\",\"database\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"circle\",\"box\"],\"title\":[\"<b>node<\\/b>= Brain small vessel disease 1 with or without ocular\\nanomalies<br><b>node_type<\\/b>= disease_name<br><b>q<\\/b>= 0.013<br><b>CellType<\\/b>= Adult_Endothelial_cell_(endothelial_to_mesenchymal_transition)<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:175780<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Retinal arteriolar tortuosity<br><b>hpo_id<\\/b>= HP:0001136<br><b>disease_name<\\/b>= Brain small vessel disease 1 with or without ocular\\nanomalies<br><b>shape<\\/b>= database<br><b>name<\\/b>= Brain small vessel disease 1 with or without ocular\\nanomalies<br>\",\"<b>node<\\/b>= Retinal arteriolar tortuosity<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0.013<br><b>CellType<\\/b>= Adult_Endothelial_cell_(endothelial_to_mesenchymal_transition)<br><b>ancestor_name<\\/b>= Abnormality of head or neck<br><b>disease_id<\\/b>= OMIM:175780<br><b>ontLvl<\\/b>= 9<br><b>definition<\\/b>= The presence of an increased number of twists and turns of\\nthe retinal arterioles.<br><b>hpo_name<\\/b>= Retinal arteriolar tortuosity<br><b>hpo_id<\\/b>= HP:0001136<br><b>disease_name<\\/b>= Brain small vessel disease 1 with or without ocular\\nanomalies<br><b>shape<\\/b>= database<br><b>name<\\/b>= Retinal arteriolar tortuosity<br>\",\"<b>node<\\/b>= Polycoria<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_Stromal_cell<br><b>ancestor_name<\\/b>= Abnormality of the eye<br><b>disease_id<\\/b>= OMIM:175780<br><b>ontLvl<\\/b>= 7<br><b>definition<\\/b>= Multiple pupils.<br><b>hpo_name<\\/b>= Polycoria<br><b>hpo_id<\\/b>= HP:0011500<br><b>disease_name<\\/b>= Brain small vessel disease 1 with or without ocular\\nanomalies<br><b>shape<\\/b>= database<br><b>name<\\/b>= Polycoria<br>\",\"<b>node<\\/b>= Facial paralysis<br><b>node_type<\\/b>= hpo_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Adult_Fetal_mesenchymal_progenitor<br><b>ancestor_name<\\/b>= Abnormality of head or neck<br><b>disease_id<\\/b>= OMIM:175780<br><b>ontLvl<\\/b>= 8<br><b>definition<\\/b>= Complete loss of ability to move facial muscles innervated\\nby the facial nerve (i.e., the seventh cranial nerve).<br><b>hpo_name<\\/b>= Facial paralysis<br><b>hpo_id<\\/b>= HP:0007209<br><b>disease_name<\\/b>= Brain small vessel disease 1 with or without ocular\\nanomalies<br><b>shape<\\/b>= database<br><b>name<\\/b>= Facial paralysis<br>\",\"<b>node<\\/b>= endothelial cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.013<br><b>CellType<\\/b>= Adult_Endothelial_cell_(endothelial_to_mesenchymal_transition)<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:175780<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Retinal arteriolar tortuosity<br><b>hpo_id<\\/b>= HP:0001136<br><b>disease_name<\\/b>= Brain small vessel disease 1 with or without ocular\\nanomalies<br><b>shape<\\/b>= circle<br><b>name<\\/b>= endothelial cell<br>\",\"<b>node<\\/b>= stromal cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_Stromal_cell<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:175780<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Polycoria<br><b>hpo_id<\\/b>= HP:0011500<br><b>disease_name<\\/b>= Brain small vessel disease 1 with or without ocular\\nanomalies<br><b>shape<\\/b>= circle<br><b>name<\\/b>= stromal cell<br>\",\"<b>node<\\/b>= fibroblast<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Fetus_Fibroblast<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:175780<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Polycoria<br><b>hpo_id<\\/b>= HP:0011500<br><b>disease_name<\\/b>= Brain small vessel disease 1 with or without ocular\\nanomalies<br><b>shape<\\/b>= circle<br><b>name<\\/b>= fibroblast<br>\",\"<b>node<\\/b>= skeletal muscle satellite cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.018<br><b>CellType<\\/b>= Satellite_cells<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:175780<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Polycoria<br><b>hpo_id<\\/b>= HP:0011500<br><b>disease_name<\\/b>= Brain small vessel disease 1 with or without ocular\\nanomalies<br><b>shape<\\/b>= circle<br><b>name<\\/b>= skeletal muscle satellite cell<br>\",\"<b>node<\\/b>= smooth muscle cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0.032<br><b>CellType<\\/b>= Smooth_muscle_cells<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:175780<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Polycoria<br><b>hpo_id<\\/b>= HP:0011500<br><b>disease_name<\\/b>= Brain small vessel disease 1 with or without ocular\\nanomalies<br><b>shape<\\/b>= circle<br><b>name<\\/b>= smooth muscle cell<br>\",\"<b>node<\\/b>= mesenchymal stem cell<br><b>node_type<\\/b>= cl_name<br><b>q<\\/b>= 0<br><b>CellType<\\/b>= Adult_Fetal_mesenchymal_progenitor<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:175780<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Facial paralysis<br><b>hpo_id<\\/b>= HP:0007209<br><b>disease_name<\\/b>= Brain small vessel disease 1 with or without ocular\\nanomalies<br><b>shape<\\/b>= circle<br><b>name<\\/b>= mesenchymal stem cell<br>\",\"<b>node<\\/b>= COL4A1<br><b>node_type<\\/b>= gene_symbol<br><b>q<\\/b>= 0.013<br><b>CellType<\\/b>= Adult_Endothelial_cell_(endothelial_to_mesenchymal_transition)<br><b>ancestor_name<\\/b>= NA<br><b>disease_id<\\/b>= OMIM:175780<br><b>ontLvl<\\/b>= NA<br><b>definition<\\/b>= NA<br><b>hpo_name<\\/b>= Retinal arteriolar tortuosity<br><b>hpo_id<\\/b>= HP:0001136<br><b>disease_name<\\/b>= Brain small vessel disease 1 with or without ocular\\nanomalies<br><b>shape<\\/b>= box<br><b>name<\\/b>= COL4A1<br>\"],\"degree\":[16,4,10,2,6,6,3,3,3,3,8],\"value\":[1,13,7,15,11,11,14,14,14,14,9],\"color\":[\"#000C7D\",\"#A7018B\",\"#A7018B\",\"#A7018B\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FF7051\",\"#FFF123\"],\"label\":[\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Retinal\\narteriolar\\ntortuosity\",\"Polycoria\",\"Facial\\nparalysis\",\"endothelial\\ncell\",\"stromal\\ncell\",\"fibroblast\",\"skeletal\\nmuscle\\nsatellite\\ncell\",\"smooth\\nmuscle\\ncell\",\"mesenchymal\\nstem cell\",\"COL4A1\"],\"x\":[0.375,-1,0.5,-0.25,-1,1,0.625,0.25,0,-0.375,0.25],\"y\":[-1,-0.3333333333333334,-0.3333333333333334,-0.3333333333333334,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,0.3333333333333333,1]},\"edges\":{\"from\":[\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Retinal\\narteriolar\\ntortuosity\",\"Retinal\\narteriolar\\ntortuosity\",\"Polycoria\",\"Polycoria\",\"Polycoria\",\"Polycoria\",\"Polycoria\",\"Facial\\nparalysis\",\"endothelial\\ncell\",\"endothelial\\ncell\",\"stromal\\ncell\",\"fibroblast\",\"stromal\\ncell\",\"skeletal\\nmuscle\\nsatellite\\ncell\",\"smooth\\nmuscle\\ncell\",\"mesenchymal\\nstem cell\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\",\"Brain\\nsmall\\nvessel\\ndisease\\n1 with or\\nwithout\\nocular\\nanomalies\"],\"to\":[\"Retinal\\narteriolar\\ntortuosity\",\"Retinal\\narteriolar\\ntortuosity\",\"Polycoria\",\"Polycoria\",\"Polycoria\",\"Polycoria\",\"Polycoria\",\"Facial\\nparalysis\",\"endothelial\\ncell\",\"endothelial\\ncell\",\"stromal\\ncell\",\"fibroblast\",\"stromal\\ncell\",\"skeletal\\nmuscle\\nsatellite\\ncell\",\"smooth\\nmuscle\\ncell\",\"mesenchymal\\nstem cell\",\"COL4A1\",\"COL4A1\",\"COL4A1\",\"COL4A1\",\"COL4A1\",\"COL4A1\",\"COL4A1\",\"COL4A1\",\"endothelial\\ncell\",\"endothelial\\ncell\",\"stromal\\ncell\",\"fibroblast\",\"stromal\\ncell\",\"skeletal\\nmuscle\\nsatellite\\ncell\",\"smooth\\nmuscle\\ncell\",\"mesenchymal\\nstem cell\"],\"color\":[0.6541577599934639,0.6541577599934639,0.996374166123454,0.996374166123454,0.996374166123454,0.996374166123454,0.996374166123454,1.270827254066457,0.6541577599934639,0.6541577599934639,1.23617810837491,1.285777188884369,1.23617810837491,0.6245714291920257,0.5991659957910558,1.270827254066457,0.6541577599934639,0.6541577599934639,1.23617810837491,1.285777188884369,1.23617810837491,0.6245714291920257,0.5991659957910558,1.270827254066457,0.6541577599934639,0.6541577599934639,1.23617810837491,1.285777188884369,1.23617810837491,0.6245714291920257,0.5991659957910558,1.270827254066457],\"width\":[0.6582780204602499,0.650037499526678,1.423314013139187,1.285777188884369,1.049042203610633,0.6245714291920257,0.5991659957910558,1.270827254066457,0.6582780204602499,0.650037499526678,1.423314013139187,1.285777188884369,1.049042203610633,0.6245714291920257,0.5991659957910558,1.270827254066457,0.6582780204602499,0.650037499526678,1.423314013139187,1.285777188884369,1.049042203610633,0.6245714291920257,0.5991659957910558,1.270827254066457,0.6582780204602499,0.650037499526678,1.423314013139187,1.285777188884369,1.049042203610633,0.6245714291920257,0.5991659957910558,1.270827254066457]},\"nodesToDataframe\":true,\"edgesToDataframe\":true,\"options\":{\"width\":\"100%\",\"height\":\"100%\",\"nodes\":{\"shape\":\"dot\",\"physics\":false,\"borderWidth\":3,\"borderWidthSelected\":6,\"color\":{\"hover\":{\"background\":\"rgba(0,0,0,.5)\"},\"highlight\":{\"background\":\"#00FFFFCF\",\"border\":\"#00FFFFCF\"}},\"opacity\":0.75,\"font\":{\"color\":\"#F0FFFF\",\"strokeWidth\":2,\"strokeColor\":\"rgba(0,0,0,1)\"},\"shadow\":{\"enabled\":true,\"size\":10}},\"manipulation\":{\"enabled\":false},\"edges\":{\"arrows\":\"from\",\"color\":{\"opacity\":0.5},\"smooth\":{\"enabled\":true,\"type\":\"cubicBezier\",\"roundness\":0.5},\"shadow\":{\"enabled\":false}},\"physics\":{\"solver\":\"forceAtlas2Based\",\"enabled\":false,\"forceAtlas2Based\":{\"avoidOverlap\":0.5,\"gravitationalConstant\":-50}},\"interaction\":{\"hover\":true,\"zoomSpeed\":1}},\"groups\":null,\"width\":\"100%\",\"height\":\"60vh\",\"idselection\":{\"enabled\":false,\"style\":\"width: 150px; height: 26px\",\"useLabels\":true,\"main\":\"Select by id\"},\"byselection\":{\"enabled\":false,\"style\":\"width: 150px; height: 26px\",\"multiple\":false,\"hideColor\":\"rgba(200,200,200,0.5)\",\"highlight\":false,\"variable\":\"name\",\"main\":\"Select by name\"},\"main\":{\"text\":\"small vessel disease\",\"style\":\"font-family:Georgia, Times New Roman, Times, serif;font-weight:bold;font-size:20px;text-align:center;\"},\"submain\":null,\"footer\":null,\"background\":\"transparent\",\"igraphlayout\":{\"type\":\"full\"},\"tooltipStay\":300,\"tooltipStyle\":\"position: fixed;visibility:hidden;padding: 5px;white-space: nowrap;font-family: verdana;font-size:14px;font-color:#000000;background-color: #f5f4ed;-moz-border-radius: 3px;-webkit-border-radius: 3px;border-radius: 3px;border: 1px solid #808074;box-shadow: 3px 3px 10px rgba(0, 0, 0, 0.2);\",\"highlight\":{\"enabled\":true,\"hoverNearest\":false,\"degree\":1,\"algorithm\":\"all\",\"hideColor\":\"rgba(200,200,200,0.5)\",\"labelOnly\":true},\"collapse\":{\"enabled\":false,\"fit\":false,\"resetHighlight\":true,\"clusterOptions\":null,\"keepCoord\":true,\"labelSuffix\":\"(cluster)\"},\"events\":{\"doubleClick\":\"function(){ this.fit()}\"}},\"evals\":[\"events.doubleClick\"],\"jsHooks\":[]}</script>\n```\n\n\nRespiratory failure\n\nExample cell type-specific gene therapy targets for several severe phenotypes and their associated diseases. Each disease (blue cylinders) is connected to its phenotype (purple cylinders) based on well-established clinical observations recorded within the HPO [@Gargano2024-fc].Phenotypes are connected to cell types (red circles) via association testing between weighted gene sets ($FDR_{p,c}<0.05$). Each cell type is connected to the prioritised gene targets (yellow boxes) based on the driver gene analysis.The thickness of the edges connecting the nodes represent the (mean) fold-change from the bootstrapped enrichment tests. Nodes were spatially arranged using the Sugiyama algorithm [@Sugiyama1981-ev].\n:::\n\n\n## Supplementary Methods\n\n### Therapeutics: Gene therapy target identification\n\nDescriptions of each step in the prioritisation pipeline are as follows:\n\n1.  **start**: All phenotype-cell type association results.\n\n2.  **q_threshold**: Keep only results that were significant after multiple-testing correction (q\\<0.05).\n\n3.  **fold_threshold**: Keep only results with fold change\\>=1.\n\n4.  **keep_ont_levels**: Keep only phenotypes at certain absolute ontology levels within the HPO.\n\n5.  **keep_onsets**: Keep only phenotypes with postnatal age of onsets to circumvent technical and ethical challenges associated with antenatal gene therapeutics delivery.\n\n6.  **keep_tiers**: Keep only phenotypes with high severity Tiers.\n\n    1.  We used a combination of manual curation and automated text-based substring queries to assign each phenotype a severity Tier as characterised in a survey of healthcare professionals [(Lazarin et al., 2014)](https://paperpile.com/c/mt9IUc/U0cDI).\n\n    2.  Tier 1: Diseases that shortened life span in adolescence or earlier or resulted in intellectual disability.\n\n    3.  Tier 2: Diseases that shortened lifespan prematurely in adulthood, or resulted in impaired mobility or internal physical malformation.\n\n    4.  Tier 3: Diseases causing sensory impairments (hearing, vision, touch, pain, or other), immunodeficiency/cancer, mental illness, or dysmorphic features.\n\n    5.  Tier 4: Diseases that reduce fertility. Of the 49 phenotypes that were available in this severity ranking, we selected three that were classified as Tier 1 (the most severe disease category): mental deterioration, coma and respiratory failure.\n\n7.  **severity_threshold**: Keep only phenotypes with mean severity score equal to or below the threshold.\n\n    1.  Severity scores were computed by assigning each severity modifier term found in the HPO annotations a numerical value. In order of increasing severity:\n\n    2.  HP:0012825 \"Mild\" (Severity_score=4)\n\n    3.  HP:0012827 \"Borderline\" (Severity_score=3)\n\n    4.  HP:0012828 \"Severe\" (Severity_score=2)\n\n    5.  HP:0012829 \"Profound\" (Severity_score=1)\n\n8.  **pheno_frequency_threshold**: Keep only phenotypes with mean frequency equal to or above the threshold (i.e. how frequently a phenotype is associated with any diseases in which it occurs).\n\n    1.  Keep phenotypes with a mean frequency ≥10% or are NA by default.\n\n9.  **keep_celltypes**: Keep only terminally differentiated cell types.\n\n    1.  Of the 77 cell types tested in the Descartes cell type reference, the 40 terminally differentiated cell types were identified through a literature search. Of these, three (extravillous trophoblasts, syncytiotrophoblasts and trophoblast giant cells) were excluded as they only played a role in pregnancy [(Chang et al., 2018; Fogarty et al., 2011; Hu & Cross, 2010)](https://paperpile.com/c/mt9IUc/kncbp+PcRky+6hjdy), which would raise additional technical and ethical challenges as rAAV therapy has not yet been used to target foetuses in clinical trials.\n\n10. **keep_seqnames**: Remove genes on non-standard chromosomes.\n\n    1.  Only keep chromosomes 1-22, X, and Y.\n\n11. **gene_size**: Keep only genes \\<4.3kb in length.\n\n    1.  Due to limitations in the length of the gene that can be carried by the rAAV vector, genes with a length of \\>4.3kb were excluded.\n\n12. **keep_biotypes**: Keep only genes belonging to certain biotypes (e.g. \"protein_coding\", \"processed_transcript\", \"snRNA\", \"lincRNA\", \"snoRNA\", \"IG_C_gene\").\n\n    1.  Keep all biotypes by default.\n\n13. **gene_frequency_threshold**: Keep only genes at or above a certain mean frequency threshold (i.e. how frequently a gene is associated with a given phenotype when observed within a disease).\n\n    1.  Keep genes with a mean frequency ≥10% or are NA by default.\n\n14. **keep_specificity_quantiles**: Keep only genes in top specificity quantiles from the cell type dataset.\n\n    1.  To further narrow down genes, we extracted relevant metrics from the Descartes reference for each gene in each cell type. These included mean expression, specificity, and specificity quantiles (using 40 bins). Only genes with the most specific quantiles (39-40) were included for further analysis, as cell type-specific genes may be less likely to have off-target effects in other cell types.\n\n15. **keep_mean_exp_quantiles**: Keep only genes in top mean expression quantiles from the cell type dataset\n\n16. **end**: Final table of prioritised cell type- / phenotype-specific gene targets.\n\nFinally, for more comprehensive target search, the we removed the filters for onsets (keep_onsets=NULL), Tier (keep_tiers=NULL), severity (severity_threshold=NULL), as well as relaxed the filters for phenotype frequency threshold (pheno_frequency_threshold=c(10,NA)), gene frequency threshold (gene_frequency_threshold = c(10,NA)), gene specificity quantiles (keep_specificity_quantiles = seq(20,40)), and gene expression quantiles (keep_mean_exp_quantiles = seq(20,40)).\n\n## Supplementary Tables\n\n\n::: {#tbl-targets .cell tbl-cap='Prioritised targets' tbl-subcap='Cell type- and gene- specific targets for each phenotype. Targets were prioritised using the filtering and sorting procedure implemented in the `MSTExplorer::prioritise_targets` function.'}\n\n:::\n\n\n## Links {#links}\n\n-   **Complement system gene list**: [*https://www.genenames.org/data/genegroup/#!/group/492*](https://www.genenames.org/data/genegroup/#!/group/492)\n",
    "supporting": [],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {
      "include-in-header": [
        "<script src=\"../site_libs/htmlwidgets-1.6.4/htmlwidgets.js\"></script>\n<link href=\"../site_libs/vis-9.1.0/vis-network.min.css\" rel=\"stylesheet\" />\n<script src=\"../site_libs/vis-9.1.0/vis-network.min.js\"></script>\n<script src=\"../site_libs/visNetwork-binding-2.1.2/visNetwork.js\"></script>\n"
      ]
    },
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}